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A B S T R A C T
Background
Drug strategies internationally recognize link between drug use and crime. This review consider interventions for drug-using offenders
under the care of the criminal justice system.
Objectives
To assess the effectiveness of interventions for drug-using offenders in reducing criminal activity and drug use in the courts, secure
establishments and community-based settings.
Search methods
Twenty two electronic databases were searched (1980 to 2004). Internet sites and experts in the field were contacted for further
information.
Selection criteria
Randomised Controlled Trials designed to reduce, eliminate or prevent relapse in drug using offenders
Data collection and analysis
Two authors independently assessed trials for inclusion. Data were extracted by one author and double checked.
Main results
Twenty four studies, 8936 participants, met the inclusion criteria. Results show that comparing a court-based community pre-trial
release with drugs testing and sanctions versus routine pre-trial, for arrest at 90 days results favoured the comparison group OR 1.33
(95% CI 1.04 to 1.70). Comparing therapeutic community with aftercare with a mental health programme with a waiting list control,
considering incarceration at 12 months OR 0.37 (95% CI 0.16 to 0.87), results in favour of the treatment Comparing intensive
supervision with routine parole/probation, for recidivism OR 1.98 (95% CI 1.01 to 3.87) results in favour of comparison group, no
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statistically significant difference between the groups for arrest OR 1.49 (95% CI 0.88 to 2.51), drug arrest OR 1.10 (95% CI 0.50 to
2.39), conviction OR 0.93 (95% CI 0.55 to 1.58 ) and incarceration at one year OR 0.88 (95% CI 0.50, 1.54). Comparing intensive
supervision and increased surveillance with intensive supervision alone, no statistically significant difference between the groups for
recidivism OR 2.09 (95% CI, 0.86 to 5.07), arrest OR 1.22 (95% CI 0.51 to 2.88]), drug arrest, OR 1.29 (95% CI 0.35 to 4.85),
conviction OR0.1.14 (95% CI, 0.22, to 5.91) and incarceration OR 1.30 (95% CI 0.39, to 4.30]) at one year.
Authors’ conclusions
Limited conclusions can be drawn about the effectiveness of drug treatment programmes for drug-using offenders in the courts or
the community. This is partly due to the broad range of studies and the heterogeneity of the different outcome measures presented.
Therapeutic communities with aftercare show promising results for the reduction of drug use and criminal activity in drug using
offenders. Standardisation of outcome measures and costing methodology would help improve the quality of research conducted in
the area.
P L A I N L A N G U A G E S U M M A R Y
Therapeutic communities with aftercare in secure settings may reduced drug misuse and criminal activity.
A number of policy directives are aimed at enabling people with drug problems to live healthy, crime free lives. Drug-using offenders
naturally represent a socially excluded group who may experience problems in relation to their drug use. A number of studies and
previous systematic reviews have considered the effectiveness of drug treatment interventions for drugmisusers in the general population,
mixed populations of offenders and non-offenders, drug treatment in a specific setting or country with limited outcome measures.
This review focuses on drug treatment for offenders across a number of different settings. A number of studies have been conducted
displaying a wide range of outcome measures with varying methodological quality. Little information is provided on the costs and cost-
effectiveness of such interventions. Promising results are shown for therapeutic communities with aftercare.
B A C K G R O U N D
National drug strategies in countries worldwide recognize the link
between drug use and crime, and consequently acknowledge the
role of the criminal justice system in implementing policies. All
of the European Union members’ national strategies that are out-
lined in the European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA 2002) review consider treatment interven-
tions in the criminal justice system. Similarly the Australian Na-
tional Drug Strategy (Australian Gov 2004) aims to ’improve ac-
cess to treatment programmes and services (including diversion
programmes) in the criminal justice system’ (AustralianGov 2004,
p.8). To demonstrate how national strategies influence criminal
justice system approaches, amore detailed description is presented,
using current policy initiatives developed in England and Wales.
One of the four overarching aims of the UK National Drug Strat-
egy (Home Office 1999) is to enable people with drug problems
to live healthy, crime-free lives by increasing the participation of
problem drug misusers (including offenders), in drug treatment
programmes. A further strategy target is to reduce levels of repeat
offending amongst drug-misusing offenders by 25% by 2005 and
50% by 2008. In England Drug Action Teams (DAT) work to-
wards these targets, identifying people with drug misuse problems
in the criminal justice system and providing them with a mecha-
nism for treatment via such schemes as Arrest Referral and Drug
Treatment and Testing Orders (DTTO).
More recently, the Updated National Drug Strategy of Septem-
ber 2004 (seewww.drugs.gov.uk/ReportsandPublications/Nation-
alStrategy/1038840683) introduced the Drug Interventions Pro-
gramme. Formerly known as the Criminal Justice Interventions
Programme (CJIP) the strategy aims to take advantage of oppor-
tunities within the criminal justice system by tracking drug-mis-
using offenders, many of whom are difficult to access by other
approaches and, by doing so, moving them away from drug use
and crime.
This beginning-to-end support system supports the new Crim-
inal Justice Act (Nat Probation 2004), which focuses on a uni-
fied offender management process, joining both Prison and Pro-
bation Services together through the National Offender Manage-
ment Service (NOMS). Similar alliances have also been developed
between the National Health Service (NHS) and the HM Prison
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Service with the introduction in England and Wales of the Future
Organisation of Prison Healthcare (NHS/HMP 1999) and the
Research andDevelopment Strategy for PublicHealth for England
and Wales (DOH 2001). These policies acknowledge the need to
target specifically vulnerable and socially excluded groups, such as
drug-misusing offenders. It is further suggested that such inequal-
ities in healthcare should be reduced by the identification of best
practice and proven effectiveness, however there is little research
to-date that has reported on systematic evaluations of drug treat-
ment programs for offenders in the UK and internationally.
The following section provides a brief overview of the current re-
search describing: 1) the health and social inequalities between
prisoners and the general population, 2) the use of treatment pro-
grammes for substance misuse and 3) current studies which have
assessed drug treatment interventions for offenders.
Regardless of whether offenders are in prison or not, they naturally
represent a socially excluded group One of the many differences
identified between offenders and the general population is in re-
lation to drug use and subsequent health problems. Studies that
have looked at the prevalence of drug dependence in UK pris-
ons have reported between 10% (Gunn 1991) and 39% (Brooke
1996); in the general population it is known to be much lower.
This work is supported by a further study (Mason 1997) which
evaluated a consecutive sample of 548 remand prisoners who were
comprehensively screened for substance misuse; 382 (70%) gave
a history of illicit drug use at some point in their lives, with 33%
reaching the current misuse or dependency criteria. Similar trends
have been reported in many countries, and in the US it is recog-
nised that many offenders are in need of treatment to tackle their
drug use (Lo 2000). Whilst these health problems are well docu-
mented there has been little emphasis to date on the proven sys-
tematic effectiveness of current treatment programmes specifically
for offenders (McMurran 2000; Shaw 2000).
There are wide ranges of different treatments for substance mis-
use. These include: detoxification, maintenance prescription, an-
tagonist prescription, therapeutic communities, motivational en-
hancement therapy, counselling and psychotherapy, cognitive-be-
havioural therapies, family relationship therapies, community re-
inforcement and combinations of the above. Many of these pro-
grammes have been traditionally used with drug-misusers in the
community and have been adopted for use in the criminal justice
system.
Some treatment programmes, such as cognitive-behavioural ap-
proaches, including self-monitoring, goal setting, self-control
training, interpersonal skills training, relapse prevention, group
work and lifestyle modification have shown signs of success with
offenders (Baldwin 1991; Day 1993; Little 1991; Peters 1992;
Platt 1980; Shewan 1996). Furthermore, evidence suggests that
the effectiveness of drug treatment is directly related to the length
of time an individual remains in treatment, and whether the of-
fender enters voluntarily or under some form of coercion (Anglin
1990; Anglin 1992; Falkin 1992).
Despite these findings two reports (McMurran 2000; Shaw 2000)
suggested that the treatment of drug withdrawal and other treat-
ment interventions for offenders are inadequate for this specific
population and we still require information to assess:
(1) What works best (i.e. treatment type, intensity and duration)?
(2) With whom, and with what types of substance?
(3) With what client characteristics (e.g., age, gender, ethnicity)?
(4) Under what conditions (i.e. prisons, special hospitals, pro-
bation in the community, arrest referral schemes, diversion from
court)?
More recently international concerns have focused on the cost
and cost-effectiveness of such interventions, and whether they are
effective in reducing both criminal activity and drug-use. Some
evidence can be drawn from systematic reviews completed in the
area. These have concentrated on: (1) specific drug treatments for
the general population, (2) drug treatments more generally for a
mixed population (i.e., contains offenders and non-offenders), (3)
drug treatments for offenders in a specific setting (4) drug treat-
ments for offenders, but limited to a specific country (5) outcome
measures.
Specific drug treatments for the general population and drug
treatments for generally mixed populations have concentrated
on: naltrexone maintenance treatment for opioid dependence,
the efficacy of methadone maintenance, and drug abuse treat-
ment of comparison group studies (Marsch 1998; Minozzi 2006;
Prendergast 2002). These reviews do not however, focus specifi-
cally on offenders under the care of the criminal justice system.
Systematic reviews that have been completed on offender popula-
tions or in correctional settings have been limited to focusing on
either one setting area such as community-based programs, cor-
rections-based and out-patient treatment (Chanhatasilpa 2000;
Mitchell 2000; Pearson 1999; Taxman 2002), or have focused
on literature from only one country (e.g., Germany or the USA)
(Chanhatasilpa 2000; Egg 2000). These reviews help to fulfil some
of the gaps highlighted by the literature, but do not attempt to
compare different interventions in different treatment settings.
Outcome measures in the systematic reviews focus on either re-
cidivism in correctional or community settings (Chanhatasilpa
2000; Egg 2000; Pearson 1999) or specific drug and property re-
lated criminal behaviour for methadone maintenance treatment
(Marsch 1998). A recent systematic review commissioned by the
Home Office for England and Wales focused on the effectiveness
of criminal justice and treatment programmes in reducing drug re-
lated crime, but did not specifically focus on offenders (Holloway
2005). Additionally, none of the above reviews consider the im-
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pact of the intervention on both criminal activity and drug misuse
in a number of different settings or interventions.
The current review will fulfil this gap, focusing on the interna-
tional literature, it will provide a unique comprehensive overview
of the research literature relating to the effectiveness of interven-
tions for drug-misusing offenders. In order to address this broad
topic a series of questions will consider the effectiveness of dif-
ferent interventions in different settings (e.g. the courts, secure
establishments and the community), in relation to both criminal
activity and drug misuse. The review will additionally report de-
scriptively on the costs of such treatment programs. The cost and
cost-effectiveness data has not been presented in previous system-
atic reviews in this area (e.g. Holloway 2005).
O B J E C T I V E S
To assess the effectiveness of interventions for drug-misusing of-
fenders in reducing criminal activity and drug misuse across a
range of criminal justice settings. The review addressed the fol-
lowing questions:
Court-based
(1) Do court-based interventions for drug-misusing offenders re-
duce criminal activity?
(2) Do court-based interventions for drug-misusing offenders re-
duce drug use?
Secure establishment-based
(1) Do secure establishment-based interventions for drug-misus-
ing offenders reduce criminal activity?
(2) Do secure establishment-based interventions for drug-misus-
ing offenders reduce drug use?
Community-based
(1) Do community-based interventions for drug-misusing offend-
ers reduce criminal activity?
(2) Do community-based interventions for drug-misusing offend-
ers reduce drug use?
The review additionally considered the effectiveness of different
types of interventions in relation to drug use and re-offending
behaviour.
M E T H O D S
Criteria for considering studies for this review
Types of studies
The current review forms part of a larger Department of Health
for England and Wales-funded project (Perry submitted submit-
ted), which also includes studies that have a comparison group,
but are not randomly assigned (i.e., experimental studies without
randomisation and controlled observational studies). For the pur-
poses of this review however, only randomised controlled trials
(RCTs) are reported.
Types of participants
Drug-misusing offenders were included in the review regardless
of gender, age, ethnicity, or psychiatric illness. Offenders were
defined as individuals who have been referred by the criminal
justice system at baseline to the study. Offenders were either in
police custody, being processed by the courts system, residing in
secure establishments (e.g., special hospitals, prisons), or based in
the community (i.e., under the care of the probation service).
Types of interventions
The review included any evaluated intervention; a component of
which is designed to reduce, eliminate or prevent relapse to drug
use. Types of interventions were further classified into the cate-
gories presented below and analysed separately. The comparison
group of drug-misusing offenders was not restricted to a no treat-
ment control; studies that contained comparisons with another
intervention or a minimal treatment group (i.e. any reduced com-
ponent of the intervention, such as therapeutic community with
intensive aftercare compared to therapeutic community without
intensive aftercare) were included and were similarly classified as
for the experimental interventions.
Experimental interventions:
(1) Pharmacological (e.g., methadone, naltrexone)
(2) Sentencing options (e.g., drug court, mental health court, di-
version)
(3) Monitoring (e.g., drug testing, surveillance, intensive supervi-
sion)
(4) Punitive (e.g., sanctions)
(5) Aftercare
(6) Case management
(7) Shock incarceration/boot camp
(8) Therapeutic communities
(9) Counselling
(10) Work release/vocational
(11) Cognitive skills (e.g., 12-step, relapse prevention, multi-sys-
temic therapy)
(12) Substance abuse education
Comparison interventions:
(1) Treatment as usual
(2) Minimal treatment
(3) Waiting-list control
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(4) No treatment
Types of outcome measures
Primary outcomes:
(1) Drug use as measured by:
• Self-report drug use (unspecified drug, not including
alcohol)
• Self-report drug use (specific drug)
• Addiction Severity Index (ASI drug use)
• Drug testing by urine analysis
• Drug testing by hair analysis
• Saliva analysis
• Any other additional tools (e.g., MAP or CISS)
(2) Criminal activity as measured by:
• Arrest for any offence (self-report/official records)
• Arrest for a drug offence (self-report/official records)
• Arrest for a technical violation (self-report/official records)
• Conviction for any offence (self-report/official records)
• Conviction for a drug offence (self-report/official records)
• Incarceration for any offence (self-report/official records)
• Incarceration for a drug offence (self-report/official records)
• Recidivism (self-report/official records)
• Criminal activity (self-report/official records)
Secondary outcomes:
(3) Health status (e.g., mentally disordered offenders)
(4) Information on concurrent psychiatric illness were recorded.
Where appropriate, these groups of offenders were considered sep-
arately within a meta-analysis.
(5) Cost and cost effectiveness
Resource and cost information were recorded from the papers
where available. A descriptive narrative was used to describe these
findings. Where a paper reported on the cost-effectiveness, a full
critical appraisal based on the Drummond 1997, checklist was
undertaken for those studieswith sufficient informationpresented.
Search methods for identification of studies
1. Electronic searches:
We searched
(1) MEDLINE (1966-October 2004)
(2) EMBASE (1980-October 2004)
(3) PsycINFO (1978-January 2004)
(4) Pascal (1973-November 2004)
(5) SciSearch (Science Citation Index) (1974-November 2004)
(6) Social SciSearch (Social Science Citation Index) (1972-
November 2004)
(7) ASSIA (1987-November 2004)
(8) Wilson Applied Science and Technology Abstracts (1983-Oc-
tober 2004)
(9) Inside Conferences (1993-November 2004)
(10) Dissertation Abstracts (1961-October 2004)
(11) NTIS (1964-November 2004)
(12) Sociological Abstracts (1963-September 2004)
(13) HMIC (To September 2004)
(14) PAIS (1972-October 2004)
SIGLE (1980-June 2004)
(15) Criminal Justice Abstracts (1968-December 2003)
(16) National Research Register (March 2004)
(17) Current Controlled Trials (January 2004)
(18) Drugscope (February 2004)
(19) SPECTR (March 2004)
The search strategy was restricted to studies that were published
or unpublished from 1980 onwards. By using this date the review
encompasses a large body of research, allowing comparisons to
be drawn concerning trends in quality assessment across time. A
scoping review indicated that research prior to 1980 would bare
little relevance on current treatment options.
Search strategies were developed for each database in order to ex-
ploit the search engine most effectively and to make use of any
controlled vocabulary. The search strategies were not designed to
restrict the results to RCTs as the current review forms part of a
larger Department of Health-funded project, which also includes
studies that have a comparison group, but are not randomly as-
signed (i.e., experimental studies without randomisation and con-
trolled observational studies). All searches included any language.
See ’ Additional Table 1;Table 2; Table 3; Table 4; Table 5; Table
6; Table 7; Table 8; Table 9; Table 10; Table 11; Table 12; Table
13’ for each search strategy.
A range of relevant Internet sites including those of the Home of-
fice, National Institute of Drug Abuse (NIDA) and European as-
sociation of libraries and information services on alcohol and other
drugs (ELISAD). Directory web sites, including OMNI (http://
www.omni.ac.uk) were searched for further relevant web sites.
2. Reference Checking
Attempts to identify further studies were made by examining the
reference lists of all retrieved articles. Searches of the catalogues of
relevant organisations and research founders were also undertaken.
3. Personnel communication
Experts were contacted and asked of their knowledge of other
studies, published or unpublished, relevant to the review article.
Data collection and analysis
Study Selection
Two independent authors inspected the search hits by reading the
titles and abstracts. Each potentially relevant study located in the
search was obtained as a full article and independently assessed for
inclusion by two authors. In the case of discordance, a third inde-
pendent author arbitrated. Where it was not possible to evaluate
the study because of language problems or missing information
the studies were classified as ’translation/information required to
determine decision’ until a translation or further details was pro-
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vided. The pre-screening criteria are divided into eight key ques-
tions.
Pre-screening criteria
• (1) Is the document written in 1980 or later? [If “no,”
exclude document]
• (2) Is the document an empirical study? [If “no” exclude
document]
• (3) Does the study evaluate an intervention, a component
of which is designed to reduce, eliminate, or prevent relapse with
drug-using offenders?
(E.g. drug-using is implied if the program is targeted at reducing
drug use in a group of individuals, and/or can be ascertained from
the background characteristics of the group)
(E.g., offenders residing in special hospitals, prisons, the commu-
nity (i.e., under the care of the probation service) or offenders who
are diverted from court or placed on arrest referral schemes for
treatment).
[If “no” exclude document]
Note: the entire sample need not be drug-using.
• (4) Are the participants referred by the criminal justice
system at baseline?
Note: the entire sample needs to be offenders.
[If “no” exclude document]
• (5) Does the study report pre and post-program measures of
drug use?
Note: pre and post measures must be the same before and after,
e.g. use vs. abstinence. Where measures are not the same, these
papers should be excluded.
[If “no” to question 5 & 6 then exclude document]
OR (Note: studies do not need to include both drug and crime
outcomes.)
• (6) Does the study report pre and post-program measures of
criminal behaviour?
Note: pre and post measures must be the same, but setting (e.g.,
prison) could be used to infer incarceration (pre) vs. re-incarcera-
tion (post). Where measures are not the same, these papers should
be excluded.
[If “no” to both 5 & 6 then exclude document]
• (7) Does the study include a comparison group?
(E.g. this could include a control or minimal treatment group or
another intervention group.)
[If “no” exclude document]
• (8) Do the outcome measures refer to the same length of
follow-up for two groups?
(E.g. a paper would be excluded that reported outcome measures
for the intervention at one month and the control group at six
months.)
[If “no” exclude document]
Assessment of methodological quality
Two independent reviewers assessed each study formethodological
quality using the Centre for Reviews and Dissemination Guide-
lines (CRD 2001), using ratings of ’adequate’, ’partial’, ’reported’
’inadequate’ and ’unknown’. Allocation concealment was also as-
sessed using theCochrane ratings of A, B,C andD(Higgins 2005).
The quality evaluation was not used as a criterion for exclusion
and inclusion, but the limits were described and are discussed in
the relevant sections of the review. The quality assessment consid-
ered the following items:
Assessment of baseline characteristics.
This question will assess whether the groups were similar at base-
line with respect to criminal and drug history characteristics.
We used the following classifications:
(A) Yes: reviewer consults list of baseline characteristics, author
comments and any statistical tests and decides that the character-
istics are similar.
(B) No: reviewer consults list of baseline characteristics, author
comments and any statistical tests and decides that the character-
istics are not similar.
(C) Unknown: insufficient information is provided to assess the
similarity of baseline characteristics.
Blinding methodology.
This question will assess whether the outcome assessors were ade-
quately blinded to treatment allocation.
We used the following classifications:
(A) Adequate: independent person or panel or (self ) assessments
in watertight blind conditions.
(B) Inadequate: clinician is assessor in trial on drugs with clear
side effects or a different influence on outcomes.
(C) Unknown: no statements on procedures and not deducible.
Loss to follow-up .
This question will assess whether loss to follow-up was adequately
reported.
We used the following classifications:
(A) Adequate: number randomisedmust be stated. Number(s) lost
to follow-up (dropped out) stated or deducible (from tables) for
each group and reasons summarised for each group.
(B) Partial: numbers, but not the reasons (or vice versa).
(C) Inadequate: numbers randomised not stated or not specified
for each group.
(D) Unknown: no details provided in text.
Allocation concealment
We used the following classifications:
(A) Low risk of bias: adequate allocation concealment, i.e. cen-
tral randomisation (e.g. allocation by a central office unaware of
subject characteristics), pre-numbered or coded identical bottles
or containers which are administered serially to participants, drug
prepared by the pharmacy, serially numbered, opaque, sealed en-
velopes, on-site computer system combined with allocations kept
in a locked unreadable; computer file that can be accessed only
after the characteristics of an enrolled participant have been en-
tered or other description that contained elements convincing of
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concealment.
(B)Moderate risk of bias: unclear allocation concealment, inwhich
the authors either did not report an allocation concealment ap-
proach at all or report an approach that did not fall in the category
A or C.
(C) High risk of bias: inadequate allocation concealment, such as
alternation or reference to case numbers, dates of birth, day of the
week. Any procedure that is entirely transparent before allocation,
such as an open list of random numbers or other description that
contained elements convincing of not concealment.
(D) No allocation concealment used: when reviewers have not
used this method of rating study quality, i.e. for studies which are
not randomised or quasi randomised.
Data extraction
The first autho extracted data by and confirmed by the second
reviewer. Data extraction tables were used to present a narrative
description of the papers included in the review. Those papers
excluded from the second stage of pre-screening are presented
in exclusion tables, alongside the reasons for exclusion. Papers
are presented according to setting and further divided into broad
themes of populations, intervention and outcome measures. This
helped to categorise similar studies together.
Data synthesis
A series of meta-analyses and a narrative review were performed
where appropriate to address each of the key questions outlined in
the objectives for each of the settings, intervention categories and
nominated outcomes. The narrative tables included a presentation
of the study details (e.g., author, year of publication, and country
of study origin), study methods (e.g., random assignment), partic-
ipants (e.g., number in sample, age, gender, ethnicity, age, mental
health status) interventions (e.g., description, duration, intensity
and setting), outcomes (e.g., description, follow-up period and re-
porting mechanism), resource and cost information and resource
savings (e.g., number of staff, intervention delivery, estimated costs
and estimated savings) and notes (e.g., methodological and quality
assessment information).
Statistical analysis
The Revman software package was used to perform a series of
meta-analyses for continuous and dichotomous outcome mea-
sures.Where appropriate, sensitivity analyses was conducted. Tests
for homogeneity were conducted to assess the appropriateness of
themeta-analysis. Statistical advice was provided by a statistician at
the University of York. Where appropriate presentation of this in-
formation was generated via forest plots, and Odds Ratios (ORs).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The search strategies revealed a total of 8,217 titles and abstracts
of potential relevance. Screening reduced this to 90 studies eligible
for further evaluation. The 90 studies resulted in 36 randomised
controlled trials (RCTs). Of these 36 trials, 12 were excluded from
the review, leaving a total of 24 RCTs.
Excluded studies
The 12 excluded trials had threemain reasons for exclusion. Firstly,
the lack of an appropriate comparison group (Stevens 1998S).
Secondly, the outcome measures were not appropriately measured
at pre- and post-test (Anglin 1999; Dembo 2000; Dugan 1998;
Grohman 2002; Harrell 2001; Henggeler 1991; Henggeler 2002;
Messina 2000; Nemes 1998; Nemes 1999). Thirdly, studies were
excluded where follow-up periods were not equivalent (Dembo
2000; Di Nitto 2002).
Included studies
The included studies display data from 19 publications describing
24 RCTs. Of these 24 RCTs, seven were conducted in a court set-
ting, these were divided into monitoring interventions (4 studies)
and sentencing interventions (3 studies). 4 were conducted in a
secure establishment setting, these included interventions focus-
ing on therapeutic communities (3 studies) and pharmacological
interventions (1 study). The remaining and 13 were conducted in
the community. These were divided intomonitoring interventions
(9 studies), pharmacological interventions (1 study), aftercare (1
study) and cognitive skills training (2 studies).
Court setting: Monitoring interventions
Four of the seven court-based studies focused on monitoring in-
terventions. All of these studies originated from one publication,
which used four separate samples to assess the effectiveness of com-
munity-based pre-trial release with drug testing and sanctions in
comparison to routine pre-trial release (Britt 1992 a; Britt 1992 b;
Britt 1992 c; Britt 1992 d). Across these studies, drug-misusing of-
fenders were randomly assigned to an active monitoring interven-
tion or treatment as usual. The duration of the intervention was
not reported. The sample size across the 4 studies totaled 2,007
although it is not possible to determine the number assigned in
studies 3 and 4 (Britt 1992 c; Britt 1992 d). Details about the
participants’ gender, psychiatric diagnosis and drug and or alcohol
use were not reported. All four studies measured arrest, using data
from official records at three-month and seven to nine-month fol-
low-up periods.
Court setting: Sentencing interventions
The three remaining court-based studies examined sentencing in-
terventions. Two studies assessed the effectiveness of drug courts
compared to routine probation and/or parole; the later of these
studies examined the same sample of participants across multi-
ple follow-up periods (Deschenes 1994; Gottfredson 2002). The
other study assessed the effectiveness of a mental health drug court
with ACT (assertive community treatment) case management in
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comparison to treatment as usual (Cosden 2003). Across these
studies, drug-misusing offenders were randomly assigned to an ac-
tive sentencing intervention, treatment as usual or routine parole
or probation. The duration of the interventions varied from 6 to
24 months. The sample size across the four studies varied from
235 to 639 participants. Over half of all participants in all of the
studies were male, and in one study all participants were mentally
disordered (Cosden 2003). Drug use at baseline was reported in all
participants in two of the studies (Deschenes 1994; Gottfredson
2002). Only one study measured drug use (Cosden 2003), using
self-report data from the Addiction Severity Index (ASI) at 12-
month follow-up. Using data from official records the other two
studies reported on arrest, drug arrest, drug charge and convic-
tion at between 6 and 24 months (Deschenes 1994; Gottfredson
2002).
Secure establishment: Therapeutic community interventions
Five publications evaluating three RCTs were found to examine
secure establishment-based therapeutic community interventions.
Three publications produced one study using the same sample
of participants across multiple follow-up periods assessing the ef-
fectiveness of a prison-based AMITY therapeutic community fol-
lowed by community-based residential aftercare, which was com-
pared to a waiting list control (Wexler 1999). Of the remaining
two studies, one study assessed the effectiveness of a CREST work
release transitional therapeutic community in comparison to rou-
tine work release (Nielsen 1996). The full data set is reported here
although it was found that the effects of treatment are no longer
observed when considering the female participants only. The final
study assessed the effectiveness of a Personal Reflections therapeu-
tic community followed by community-based aftercare, whichwas
compared to a prison-based mental health program (Sacks 2004).
Across these studies, drug-misusing offenders were randomly as-
signed to an intervention of a therapeutic community (sometimes
followed by aftercare) or to a waiting list control; a prison-based
mental health program or routine work release. The duration of
the interventions ranged from 6 to 24 months. The sample size
across the three studies ranged from 236 to 715. Two studies con-
tained only male participants, whereas the Nielsen 1996 study
contained both male and female participants. Two studies con-
tained solelymentally disordered participants (Sacks 2004;Wexler
1999). Drug use history was reported in the Nielsen 1996 and
Wexler 1999 studies, and both drug and alcohol use was reported
in the Sacks 2004 study. The three studies measured drug use,
recidivism criminal activity and incarceration. Drug use was re-
ported using self-report data between 6 and 18-month follow-up
periods. Recidivism, criminal activity and incarceration reported
using data from official records between 6 and 60 months.
Secure establishment: Pharmacological interventions
One study assessed the effectiveness of a pharmacological inter-
vention, randomly assigning drug-using offenders to prison-based
methadonemaintenance treatment or awaiting list control (Dolan
2003). The average duration of the intervention was 144 days
(range 72-530). The sample size of participants was 382; all were
male with no psychiatric history being reported. All participants
had a drug use history. The study measured drug use using data
from hair analysis at two, three and four-month follow-ups. Only
participants that had been in continuous custody between assign-
ment and follow-up were included.
Community: Monitoring interventions
Monitoring interventions were evaluated in eight studies, seven of
which were extracted from one publication, using separate samples
to assess the effectiveness of intensive supervision and surveillance
in comparison to routine parole (Petersilia 1992 a; Petersilia 1992
b; Petersilia 1992 c; Petersilia 1992 d) and to assess the effective-
ness of intensive supervision and surveillance in comparison to
intensive supervision alone (Petersilia 1992 e; Petersilia 1992 f;
Petersilia 1992 g). The remaining study evaluated the effectiveness
of parole with varying frequencies of drug testing in comparison
to routine parole (Haapanen 2002). Across these studies, drug-
using offenders were randomly assigned to different monitoring
conditions. The duration of the intervention ranged between 6
and 24 months. The sample size across the studies ranged from
50 to 1958. Across all samples participants included both male
and female offenders, with no history of psychiatric disorder re-
ported. The majority of participants had a drug offending history,
but the drug testing evaluation also contained offenders who were
not drug-using (Haapanen 2002). Alcohol use was not reported.
The seven Petersilia studies (Petersilia 1992 a; Petersilia 1992 b;
Petersilia 1992 c; Petersilia 1992 d; Petersilia 1992 e; Petersilia
1992 f; Petersilia 1992 g) measured recidivism, arrest, drug arrest,
conviction and incarceration using data from official records at
one-year follow-up. The Haapanen 2002 study reported arrest at
24 and 42-month follow-up periods.
Community: Pharmacological interventions
One study assessed the effectiveness of a naltrexone program and
routine parole in comparison to routine parole (Cornish 1997),
randomly assigning drug-using offenders to a pharmacological in-
tervention or no treatment. The duration of the intervention was
six months. The sample size was 51 and included both male and
female participants, with no psychiatric history reported. All par-
ticipants had a drug history, but alcohol use was not reported.
The study measured incarceration using official data from at six
months.
Community: Aftercare interventions
One study assessed an aftercare intervention by randomly as-
signing drug-using offenders to a community-based opportunity
to succeed aftercare program or to routine parole or probation
(Rossman 1999). The duration of the intervention was between
one and two years. The sample contained 398 participants, com-
prised of both male and female offenders, with psychiatric diag-
nosis, drug and alcohol use not reported. The study measured any
marijuana use, intense marijuana use, any hard drug use, intense
hard drug use and drug dealing, using self-report data at between
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3-month and 12-month follow-up periods.
Community: Case management interventions
One study assessed the effectiveness of a community-based case
management intervention. In this study, drug-using offenderswere
randomly assigned to ACT (assertive community treatment) case
management or to routine parole (Martin 1993). The duration
of the intervention was six months. The sample size was 188 and
included only the subset of participants for which the necessary
follow-up period had elapsed. Both male and female offenders
were included; psychiatric diagnosis and alcohol history were not
reported. Drug history and offending history was apparent in all
participants. The study measured incarceration, using data from
official records at six-month follow-up and drug use, using data
from self-report at six-month follow up.
Community: Cognitive skills training interventions
Two studies examined cognitive skills training. The effectiveness
of multi-systemic therapy delivered in the home and community
was compared to community services as usual (Henggeler 1999;
Schoenwald 1996) and a social support program was compared to
drug testing and routine parole, and also to routine parole (Hanlon
1999). The duration of the interventions ranged from 5 months
to 12 months. The sample size across the two studies ranged from
118 to 536; both studies included male and female offenders.
The Henggeler 1999 study focused on juvenile offenders only;
the majority of these participants also had a psychiatric diagnosis.
Drug use was reported in the Hanlon et al. (1999) study, and
both drug and alcohol history were reported in the Henggeler
1999 study. The Henggeler 1999 study measured drug use and
delinquency, using data from self-report at post treatment and six
months follow-up. The Hanlon 1999 study reported arrest and
incarceration, using data from official records at one-year follow-
up.
Risk of bias in included studies
Randomization: All the studies were described as randomised,
but only 4 of the 24 RCT studies reported adequate methods
of randomisation (Cosden 2003; Deschenes 1994; Dolan 2003;
Haapanen 2002). Themost common reason for the studies not be-
ing rated as adequate was either unclear reporting of the randomi-
sation methodology or unacceptable methods of randomisation
such as alternation. In some studies the randomisation methodol-
ogy may have been acceptable, but the authors did not describe the
methodology. Consequently, such studies received a poor rating
by the reviewers.
Characteristics at baseline: Of the 24 studies, 7 reported that
participants’ drug history was similar across the groups at baseline
(Deschenes 1994; Dolan 2003; Haapanen 2002; Petersilia 1992
a; Petersilia 1992 c; Petersilia 1992 g; Wexler 1999). A greater
number of the studies (n=18) reported similar criminal history
characteristics at baseline (Britt 1992 a; Britt 1992 b; Britt 1992
c; Britt 1992 d; Cosden 2003; Deschenes 1994; Dolan 2003;
Gottfredson 2002; Haapanen 2002; Henggeler 1999; Petersilia
1992 a; Petersilia 1992 b; Petersilia 1992 c; Petersilia 1992 e;
Petersilia 1992 f; Petersilia 1992 g; Sacks 2004; Wexler 1999)
Allocation concealment: Across the 24 studies only 4 were allo-
cated an A for adequate allocation concealment (Cosden 2003;
Deschenes 1994; Dolan 2003; Haapanen 2002). The majority
of the studies (n=14) were categorised as moderate risk of bias
and were rated as B (Cornish 1997; Gottfredson 2002; Henggeler
1999; Martin 1993; Nielsen 1996; Petersilia 1992 a; Petersilia
1992 b; Petersilia 1992 c; Petersilia 1992 d; Petersilia 1992 e;
Petersilia 1992 f; Petersilia 1992 g; Sacks 2004; Wexler 1999).
The description of the random allocation concealment for the five
remaining studies was unclear, representing a high risk of bias and
rated as C (Britt 1992 a; Britt 1992 b; Britt 1992 c; Britt 1992 d;
Hanlon 1999).
Follow-up: Only seven studies reported loss to follow-up with
the reasons adequately described (Deschenes 1994; Dolan 2003;
Haapanen 2002;Henggeler 1999; Rossman 1999; Rossman 1999;
Wexler 1999).
Effects of interventions
Of the 24 RCT studies 15 were included in a series of meta-analy-
ses. Tests for heterogeneity at the 0.01 level revealed that across all
of the meta-analyses the studies were found to be homogeneous.
Odds Ratios (OR) were used to investigate the results of combin-
ing dichotomous outcome measures. A random effects model was
used to account for the fact that the participants did not come
from a single underlying population.
• COURT-BASED INTERVENTIONS
Monitoring interventions
Four studies were found to evaluate court-based monitoring inter-
ventions. All four studies originated from one publication, which
used four separate samples to assess the effectiveness of pre-trial
release with drug testing and sanctions in comparison to routine
pre-trial release (Britt 1992 a; Britt 1992 b; Britt 1992 c; Britt
1992 d).
(1) Drug use
The studies did not report on drug use.
(2) Criminal activity
All four studies measured arrest, using data from official records at
three and seven to nine-month follow-up periods. A meta-analysis
combining studies 3 and 4 (Britt 1992 c; Britt 1992 d) showed
a significant OR for arrest at 90 days favouring the comparison
group OR 1.33 (95% CI, 1.04 to 1.70), see comparison 01, out-
come 01.
Sentencing interventions
Three studies were found to evaluate court-based sentencing in-
terventions. Two studies assessed the effectiveness of drug courts
compared to routine probation and/or parole; the later of these
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studies examined the same sample of participants across multi-
ple follow-up periods (Deschenes 1994; Gottfredson 2002). The
other study assessed the effectiveness of a sentencing intervention
(mental health drug court) combined with ACT (assertive com-
munity treatment) case management, in comparison to treatment
as usual (Cosden 2003). None of these studies were homogenous
enough to combine in a meta-analyses and the results from each
singular study are presented below.
(1) Drug use
One study measured drug use (Cosden 2003), using self-report
data from the Addiction Severity Index (ASI) at 12-month follow-
up to evaluate amental health drug court combinedwith ACTcase
management. The OR was not found to be statistically significant
OR 0.00 (95% CI -0.03 to 0.03).
(2) Criminal activity
Deschenes 1994 reported arrest for any offence at 6-month follow-
up OR 1.12 (95% CI, 0.70 to 1.79) and 12-month follow-up OR
0.94 (95% CI, 0.65 to 1.37) using data from official records, and
arrest for a drug offence at 12-month follow-up OR 1.02 (95%
CI, 0.65 to 1.61) using data from official records. None of these
results were statistically significant.
Using data from official records Gottfredson 2002G reported on
arrest, conviction and drug charge at 12 and 24-month follow-up.
A significant OR was found favouring the Baltimore drug court
programme when arrest was used as an outcome measure at both
12 months OR 0.53 (95% CI ,0.31 to 0.91) and 24 months OR
0.45 (95% CI, 0.24 to 0.84).
At 12 months there was no significant effect regarding criminal
activity as measured by drug charge OR 0.65 (95% CI, 0.37 to
1.13]), however therewas at 24months OR0.57 (95%CI, 0.34 to
0.97]). The ORswere not found to be significant when conviction
was used at either 12 months OR 0.82 (95% CI 0.47 to 1.42]) or
24 months OR 0.85 (95% CI, 0.50, 1.42).
• SECURE ESTABLISHMENT-BASED
INTERVENTIONS
Therapeutic community interventions
Five publications evaluating three RCTs were found to examine
secure establishment-based therapeutic community interventions.
Three publications produced one study using the same sample
of participants across multiple follow-up periods assessing the ef-
fectiveness of a prison-based AMITY therapeutic community fol-
lowed by community-based residential aftercare, which was com-
pared to a no-treatment control (Wexler 1999). Of the remaining
two studies, one study assessed the effectiveness of a CREST work
release transitional therapeutic community in comparison to rou-
tine work release (Nielsen 1996). The full data set is reported here
although it was found that the effects of treatment are no longer
observed when considering the female participants only. The final
study assessed the effectiveness of a Personal Reflections therapeu-
tic community followed by community-based aftercare, whichwas
compared to a prison-based mental health program (Sacks 2004).
(1) Drug use
In evaluating the CREST work release therapeutic community
Nielsen 1996 reported drug use as measured by self-report at 6-
month OR 0.12 (95% CI 0.08, 0.18) and 18-month follow-up
OR 0.28 (95% CI 0.17 to 0.47]). The ORs were both found
to be statistically significant favouring the CREST work release
therapeutic community over routine work release.
(2) Criminal activity
All of the studies showed significant ORs with the criminal activity
outcome measures favouring the intervention groups. Nielsen et
al. (1996) reported criminal activity as measured by recidivism
for any offence, which referred to an offender being arrested and
charged. These outcomes were collected through self-report and
referred to 6-month OR 0.32 (95% CI 0.20 to 0.50] and 18-
month follow-up periods OR 0.36 (95% CI 0.23 to 0.58).
One meta-analyses was possible combining the Sacks 2004 and
Wexler 1999 studies focusing on the effectiveness of a therapeutic
community and aftercare in comparison to a mental health pro-
gramme and waiting list control. Incarceration at 12 months OR
0.37, (95%CI, 0.16 to 0.87), see comparison 02, outcome 01 and
following sensitivity analyses OR 0.66 (95% CI, 0.38 to 1.15),
are showed in comparison 02, outcome 02.
Pharmacological interventions
One study assessed the effectiveness of a pharmacological inter-
vention, randomly assigning drug-using offenders to prison-based
methadonemaintenance treatment or awaiting list control (Dolan
2003).
(1) Drug use
Dolan 2003 reported drug use as measured by drug testing (hair
analysis; official records) at 2 months OR 0.67 (95% CI 0.36 to
1.25), 3 months OR 0.46 (95% CI 0.25 to 0.82) and 4 months
OR 0.66 (95% CI 0.37 to 1.21) follow-up. The OR was found
to be significant at three months only, favouring the intervention
group.
(2) Criminal activity
Criminal activity was not reported on.
• COMMUNITY-BASED INTERVENTIONS
Monitoring interventions
Monitoring interventions were evaluated in eight studies, seven of
which were extracted from one publication, using separate samples
to assess the effectiveness of intensive supervision and surveillance
in comparison to routine parole (Petersilia 1992 a; Petersilia 1992
b; Petersilia 1992 c; Petersilia 1992 d) and to assess the effective-
ness of intensive supervision and surveillance in comparison to
intensive supervision alone (Petersilia 1992 e; Petersilia 1992 f;
Petersilia 1992 g). The remaining study evaluated the effectiveness
of parole with varying frequencies of drug testing in comparison
to routine parole (Haapanen 2002).
(1) Drug use
Drug use was not reported on.
(2) Criminal activity
Petersilia 1992 a; Petersilia 1992 b; Petersilia 1992 c; Petersilia
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1992 d were combined in a series of meta-analyses focusing on the
effectiveness of intensive supervision vs routine parole/probation.
A series of different outcome measures were used:
• Recidivism at one year OR 1.98 (95% CI 1.01 to 3.87) see
comparison 03, outcome 01
• Arrest at one year OR 1.49 (95% CI 0.88 to 2.51) see
comparison 03, outcome 02,
• Drug arrest at one year OR 1.10 (95% CI 0.50, to 2.39) see
comparison 03, outcome 03,
• Conviction at one year OR 0.93 (95% CI 0.55 to 1.58) see
comparison 03, outcome 04,
• Incarceration at one year OR 0.88 (95% CI 0.50 to 1.54)
see comparison 03, outcome 05,
Petersilia 1992 e; Petersilia 1992 f; Petersilia 1992 gwere combined
a series of meta-analyses focusing on the effectiveness of intensive
supervision and increased surveillance vs. intensive supervision. A
series of different outcome measures were used:
• Recidivism at one year OR 2.09 (95% CI 0.86 to 5.07) see
comparison 04, outcome 01
• Arrest at one year OR 1.22 (95% CI 0.51 to 2.88) see
comparison 04, outcome 02
• Drug arrest at one year OR 1.29 (95% CI 0.35 to 4.85) see
comparison 04, outcome 03
• Conviction at one year OR 1.14 (95% CI 0.22 to 5.91) see
comparison 04, outcome 04
• Incarceration at one year OR 1.30 (95% CI 0.39, to 4.30])
see comparison 04, outcome 05
The Haapanen 2002 study reported arrest at 24 and 42-month
follow-up periods. Comparing the four groups receiving drug test-
ing to the routine parole group revealed no significant effect sizes
at 24 months OR 0.93 (95% CI 0.71 to 1.22), OR 1.05 (95%
CI 0.79 to 1.38), OR 1.16 (95% CI 0.88 to 1,52), OR1.11 (95%
CI 0.77 to 1.59), OR 1.02 (95% CI 0.75 to 1.38]), OR 1.06
(95% CI 0.78 to 1.45) and OR 1.24 (95% CI 0.8 to 1.89]). At 42
months the only significant OR was found to favour the routine
parole group OR=1.46 (95% CI 1.05 to 2.02).
Pharmacological interventions
One study assessed the effectiveness of a naltrexone program and
routine parole in comparison to routine parole (Cornish 1997),
randomly assigning drug-using offenders to a pharmacological in-
tervention or no treatment.
(1) Drug use
Drug use was not reported
(2) Criminal activity
The Cornish 1997 study reported on incarceration using official
data from at six months. A significant OR 0.25 (95% CI 0.07
to 0.86) was found for incarceration, favouring the intervention
group.
Aftercare interventions
One study assessed an aftercare intervention by randomly as-
signing drug-using offenders to a community-based opportunity
to succeed aftercare program or to routine parole or probation
(Rossman 1999).
(1) Drug use
The Rossman 1999 study measured any marijuana use, intense
marijuana use, any hard drug use, intense hard drug use and drug
dealing, using self-report data at between 3-month and 12-month
follow-up periods. The results were inconclusive with a significant
ORS found favouring the intervention group using intense mar-
ijuana use as the outcome, OR 0.49 (95% CI 0.25 to 0.96]), yet
favouring the comparison group when drug dealing was used as
the outcome OR 2.31 (95% CI 1.40 to 3.79)
(2) Criminal activity
Criminal activity was not reported on.
Case management interventions
One study assessed the effectiveness of a community-based case
management intervention. In this study, drug-using offenderswere
randomly assigned to ACT (assertive community treatment) case
management or to routine parole (Martin 1993).
(1) Drug use
The Martin and Scarpitti (1993) study self-report drug use at
six-months follow-up did not show any significant OR (OR=
1.44[95% CI=0.66,3.12]).
(2) Criminal activity
Measuring incarceration at six-months follow-up the Martin and
Scarpitti (1993) study showed no significant OR (OR= 0.84[95%
CI 0.41,1.73]).
Cognitive skills training interventions
Two studies examined cognitive skills training. The effectiveness
of multi-systemic therapy delivered in the home and community
was compared to community services as usual (Henggeler 1999)
and a social support program was compared to drug testing and
routine parole, and also to routine parole (Hanlon 1999).
(1) Drug use
The Henggeler 1999 study measured drug use using self-report
data at post treatment OR 1.28 (95% CI 0.54 to 3.05), and at six
months OR 1.35 (95% CI 0.56 to 3.23), neither were found to
be statistically significant.
(2) Criminal activity
TheHenggeler 1999 studymeasured delinquency using self-report
data at post treatment OR 1.00 (95% CI 12.77 to 14.77), and
at six months OR 2.00 (95% CI 11.96 to 15.96]), neither were
found to be statistically significant.
The Hanlon 1999 study reported arrest using official records at
one year I vs I1 OR 0.66 (95% CI 0.41 to 1.05]), I vs. C OR 0.74
(95% CI 0.48 to 1.13), and I1 vs. C OR 1.13 (95% CI 0.67 to
1.91), and incarceration at one year I vs. I1 OR 0.90 (95% CI
0.54 to 1.51), I vs. C OR 0.74 (95% CI 0.47 to 1.16) and I1 vs.
C OR 0.82 (95% CI 0.46 to 1.44), none of the results were found
to be statistically significant.
Cost and cost effectiveness
No explicit cost data was available for the court-based interven-
tions. One study contained some information about the cost of
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providing a therapeutic community intervention (Sacks 2004). For
this intervention the additional marginal costs on top ot the spe-
cific incarceration costswereUSD$7.37per day.Cost information
was reported in seven of the community studies (Henggeler 1999;
Petersilia 1992 a; Petersilia 1992 b; Petersilia 1992 c; Petersilia
1992 d; Rossman 1999). Petesillia suggests that there is an addi-
tional cost of USD $3000 per annum (1992 prices) for intensive
probation supervision. On cost comparison, the costs per day are
lower or comparable to the additional costs per day of the thera-
peutic community in prison. Without any allowance for adminis-
tration costs, Rossman et al. (1999) suggests that the service pro-
vision cost for the opportunity to succeed scheme is about USD
$1810 for the one to two year programme. This study does provide
an estimate of the benefits of the programme in financial terms,
and were found to be similar (USD $105,339) to the service pro-
vision costs (USD $108,632). These figures were based on cost
per programme.
One study provided enough data for a detailed critique of cost
effectiveness using the Drummond Scale. Schoenwald 1996 is an
economic paper linked to the Henggeler 1999 evaluation of the
community-based multi-systemic therapy. The paper compared
services accessed by young offenders to the costs of specific pro-
gramme costs. Individual outcomes for the programme were in-
cluded in the economic analysis and the results of an additional
USD $877 cost per young person for the therapy was estimated.
D I S C U S S I O N
This systematic review provides evidence from 24 RCTs, 15 of
these were included in a series of sub-set meta analyses. Little con-
clusive evidence can be drawn from the studies conducted in the
courts or community settings. The inference of these interventions
is weakened by the limited methodological quality of some of the
RCTs, including loss to follow-up and potential baseline differ-
ences between the groups. Therapeutic community interventions,
followed by aftercare, may be promising for drug-using offenders.
This work is also supported by quasi-experimental designs (e.g.,
Inciardi 1997), but such studies are susceptible to a greater amount
of bias.
The outcome measures used in the current studies are broad rang-
ing and reflect themultidisciplinary nature of working across agen-
cies with drug-using offenders. The appropriate use of such mea-
sures is important when trying to assess the effectiveness of such
treatment programmes. Other outcome measures that might re-
flect success in treatment could perhaps include, employment.
Cost information within the studies is sparse, with only one
study providing the opportunity for a full economic evaluation
(Schoenwald 1996). This lack of information allows for little com-
parison of cost effectiveness between different types of drug treat-
ment programmes. Furthermore, very few studies include females,
juveniles and young offenders with themajority reporting onmale
adults. Development of studies focusing on these particularly vul-
nerable groups may help the development of specifically tailor
made interventions for such participants. In line with such com-
ments is the importance of selecting participants appropriately for
specifically targeted programmes. For example, incorrect selection
of participants for programmes could give misleading negative re-
sults.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Very limited conclusions can be drawn about the overall effec-
tiveness of drug treatment programmes for offenders under the
care of the criminal justice system. Promising results are highlight
the use of therapeutic communities with aftercare facilities. The
success of such programmes in secure settings maybe attributed
to the large numbers of participants completing the programme.
Maintainence and retention of such individuals in the courts or
the community is very difficult due to the often chaotic lifestyle
led by individuals attending such programmes. Such problems af-
fect the continuity of treatment programmes. Standardisation of
outcome measures for drug-using offenders should be used in a
range of different interventions and settings.
Implications for research
There is some evidence to suggest that therapeutic communities
with aftercare have some success in reducing drug use and crimi-
nal activity in drug-using offenders. There has however been lit-
tle research evaluating and developing interventions with females,
juveniles and young offenders. There is therefore perhaps a need
to develop interventions that are tailor made to the needs of these
subgroups of populations. Very limited information is provided
on the costs and resources involved in the delivery of such inter-
ventions, particularly with regards to the UK literature. Attempts
to address this gap could follow costing methodology developed
in the USA (Yates, 1999). A broad range of outcome measures
have been presented in this review reflecting the multidisciplinary
nature of working with clients across a number of different agen-
cies and criminal justice settings. Future work should consider the
most appropriate use of outcomes and produce some standardis-
ation from which comparison can be made across the literature.
Additionally, it is important to stress the need to conduct high
quality RCTs in drug misuse treatment in general. This will help
policy makers to make informed choices about the relative effec-
tiveness of treatment for specific groups of individuals.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Britt 1992 a
Methods Allocation: random assignment
Randomisation method: inadequate
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: partial
Participants 619 adults
Age not reported
Gender not reported
Ethnicity not reported
Drug use not reported
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: released pre-trial defendants
Interventions Court-based monitoring intervention vs. treatment as usual.
(I) pre-trial release & drugs testing & sanctions (n assigned not reported) vs. (C) routine pre-trial release
(n assigned not reported). Intensity and duration not reported for either group
Outcomes Arrest for any offence (official records) during the last 7-9 months at 7-9 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Britt 1992 b
Methods Allocation: random assignment
Randomisation method: inadequate
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: partial
Participants 264 adults
Age not reported
Gender not reported
Ethnicity not reported
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Britt 1992 b (Continued)
Drug use not reported
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: released pre-trial defendants
Interventions Court-based monitoring intervention vs. treatment as usual.
(I) pre-trial release & drugs testing & sanctions (n assigned not reported) vs. (C) routine pre-trial release
(n assigned not reported). Intensity and duration not reported for either group
Outcomes Arrest for any offence (official records) during the last 7-9 months at 7-9 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Britt 1992 c
Methods Arrest for any offence (official records) during the last 7-9 months at 7-9 months follow-up
Participants 234 adults
Age not reported
Gender not reported
Ethnicity not reported
Drug use not reported
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: released pre-trial defendants
Interventions Court-based monitoring intervention vs. treatment as usual.
(I) pre-trial release & drugs testing & sanctions (n assigned not reported) vs. (C) routine pre-trial release
(n assigned not reported). Intensity and duration not reported for either group
Outcomes Arrest for any offence (official records) during the last 3 months at 3 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
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Britt 1992 d
Methods Allocation: random assignment
Randomisation method: inadequate
Similar on drug use: no
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: inadequate
Participants 890 adults
Age not reported
Gender not reported
Ethnicity not reported
Drug use not reported
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: released pre-trial defendants
Interventions Court-based monitoring intervention vs. treatment as usual.
(I) pre-trial release & drugs testing & sanctions (n assigned not reported) vs. (C) routine pre-trial release
(n assigned not reported). Intensity and duration not reported for either group
Outcomes Arrest for any offence (official records) during the last 3 months at 3 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Cornish 1997
Methods Allocation:
random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: unknown
Blinding methodology: unknown
Loss to follow-up: inadequate
Participants 51 adults
Interventions Community-based naltrexone program & routine parole/probation vs. routie parole/probation
Outcomes Incarceration for technical violation (official records) during the last 6 months at 6 months follow-up
Notes
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Cornish 1997 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cosden 2003
Methods Allocation: random assignment
Randomisation method: adequate
Similar on drug use: unknown
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: partial
Participants 235 adults
Age not reported
50.2% male
70.6% European American
Drug use not reported
Alcohol use not reported
100% psychiatric history
Eligibility criteria: adults charged with a felony or misdemeanour who were booked into county jail, had at
least one prior booking and were diagnosed with a serious and pervasive mental illness and were residents
of the county involved. Pre-plea participants were required to have no previous offenses involving violence;
post-adjudication participants with prior violence were eligible if they were considered to no longer pose
a threat
Interventions Court-based sentencing and case management intervention vs. treatment as usual.
(I) mental health treatment court (MHTC) & assertive community treatment (ACT) case management
(n=137) vs. (C) treatment as usual (n=98). The (I) group received weekly or bi-weekly court supervision
and frequent contact with case managers, duration 18 months, followed by treatment as usual if required.
The (C) group received traditional court proceedings and county mental health services as usual for at
least 18 months which was less intensive than (I)
Outcomes Drug use (Addiction Severity Index, self-report) during the last 1 month at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Deschenes 1994
Methods Allocation: random assignment
Randomisation method: adequate
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 639 adults
Mean age 29.8 (s.d. not reported)
77.9% male
54.0% white
100% drug-using
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: offenders sentenced to probation for a felony drug offence of drug use or possession and
those with similar needs for treatment. Offenders were ineligible if they required inpatient counselling,
the community punishment program, specialized caseload supervision or a different type of probation
Interventions Court-based sentencing intervention vs. treatment as usual.
(I) post adjudication drug court (n=177) vs. (C) routine probation with varying frequencies of urine
testing (n=462). The (I) group received drug education classes, process groups, case management and
aftercare. The intervention consisted of three phases of treatment that last 2 months each, followed by up
to 9months of aftercare. The first phase involved weekly classes, weekly process groups, weekly twelve-step
meetings, weekly meetings with probation officers and random urine testing. The second phase involved
weekly process groups, weekly twelve-step meetings, other terms of probation and random urine tests.
The third phase involved weekly process groups and at least weekly twelve-step meetings. The aftercare
involved weekly process groups. The drug court lasted between 6 and 12 months with monthly progress
reports with rewards and sanctions. The (C) group received routine probation with varying frequencies of
urine testing (none, random once per month, or scheduled for twice a week) and visits from the probation
officer as determined by the risk/need assessment; duration not reported
Outcomes Arrest for any offence (official records) during the last 6 months at 6 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Dolan 2003
Methods Allocation: random assignment
Randomisation method: adequate
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: adequate
Loss to follow-up: adequate
Participants 382 adults & young offenders
Mean age 27 (s.d. 6)
100% male
Ethnicity not reported
100% drug-using
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: prisoners with a heroin problem, as confirmed by a detailed interview, who have at
least 4 months remaining on their prison sentence at time of interview
Interventions Secure establishment-based pharmacological intervention vs. waiting-list control.
(I) methadone maintenance (n=191) vs. waiting-list control (n=191). (I) participants were given 30mg
of methadone each day, increasing by 5mg every 3 days until 60mg was achieved; duration in treatment
varied. Duration of waiting-list was 4 months
Outcomes Drug testing (hair analysis; official records) during the last 2 months at 2 months follow-up
Drug testing (hair analysis; official records) during the last 3 months at 3 months follow-up
Drug testing (hair analysis; official records) during the last 4 months at 4 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Gottfredson 2002
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: unknown
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: partial
Participants 235 adults
Mean age 34.9 (s.d. 7.6)
74.1% male
89.4% African American
100% drug-using
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Gottfredson 2002 (Continued)
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: non-violent drug-involved adult offenders
Interventions Court-based sentencing intervention vs. treatment as usual.
(I) drug court (n=139) vs. (C) routine parole/probation (n=96). Drug court involved intensive supervision
including 3 contacts per week with the probation officer, 2 home visits per month, montlhy verification of
employment status, bi-weekly urine testing, weekly court hearings. Drug court also involved treatment for
example outpatient, methadone maintenance, inpatient or transitional housing; intensity varied according
to modality. Treatment was also available to the (C) group. Duration of drug court up to 24 months;
duration and intensity of routine parole/probation not reported
Outcomes Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Conviction for any offence (official records) during the last 12 months at 12 months follow-up
Drug charge (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 24 months at 24 months follow-up
Conviction for any offence (official records) during the last 24 months at 24 months follow-up
Drug charge (official records) during the last 24 months at 24 months follow-up
Notes Data also from: Gottfredson 2003
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Haapanen 2002
Methods Allocation: random assignment
Randomisation method: Adequate
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 1958 adults, young offenders & juveniles
Interventions Community-based routine parole & drugs testing (once/twice) vs. routine parole & drugs testing
(monthly) vs. routine parole & drugs testing (fortnightly) vs. routine parole & drugs testing (weekly) vs.
routine parole
Outcomes Arrest for any offence (official records) during the last 24 months at 24 months follow-up
Arrest for any offence (official records) during the last 42 months at 42 months follow-up
Notes I1, I2, I3, I4, C/I5?
Risk of bias
23Interventions for drug-using offenders in the courts, secure establishments and the community. (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Haapanen 2002 (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Hanlon 1999
Methods Allocation: random assignment
Randomisation method: inadequate
Similar on drug use: unknown
Similar on criminal activity: unknown
Blinding methodology: unknown
Loss to follow-up: partial
Participants 536 adults
Interventions Community-based social support program vs. weekly drugs testing & routine parole
Community-based social support program vs. routine parole
Community-based weekly drugs testing & routine parole vs. routine parole
Outcomes Arrest (official records) during the last 12 months at 12 months follow-up
Incarceration (official records) during the last 12 months at 12 months follow-up
Notes I vs I1
I vs C
I1 vs C
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Henggeler 1999
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: no
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 118 juveniles
Interventions Community-based multi-systemic therapy vs. community services as usual
24Interventions for drug-using offenders in the courts, secure establishments and the community. (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Henggeler 1999 (Continued)
Outcomes Drug use (not alcohol or marijuana; self-report) at post treatment follow-up
Drug use (not alcohol or marijuana; self-report) at 6 months post treatment follow-up
Delinquency Scale (self-report) at post treatment follow-up
Delinquency Scale (self-report) at 6 months post treatment follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Martin 1993
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: unknown
Similar on criminal activity: no
Blinding methodology: unknown
Loss to follow-up: partial
Participants 365 adults
Interventions Communit-based ACT case management vs. routine parole
Outcomes Incarceration (official records) during the last 6 months at 6 months follow-up
Drug use (self-report) during the last 6 months at 6 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Nielsen 1996
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: no
Similar on criminal activity: no
Blinding methodology: unknown
Loss to follow-up: partial
Participants 689 adults & young offenders
Age not reported
79.1% male
28.9% white
100% drug-using
Alcohol use not reported
Psychiatric history not reported
Eligibility criteria: offenders with a history of drug use who were eligible for work release or parole and
about to be released from prison
Interventions Secure establishment-based therapeutic community vs. treatment as usual.
(I) CREST work-release therapeutic community (n=248) vs. (C) routine work-release (n=441). (I) com-
prised 1 month of orientation followed by 2 months of primary treatment followed by 3 months of work
release. The (I) was intensive given the nature of the intervention. Duration of (C) also 6months, intensity
not reported
Outcomes Drug use (self-report) during the last 6 months at 6 months follow-up
Drug use (self-report) during the last 18 months at 18 months follow-up
Recidivism (arrested and charged) for any offence (self-report) during the last 6 months at 6 months
follow-up
Recidivism (arrested and charged) for any offence (self-report) during the last 18 months at 18 months
follow-up
Notes Farrell (2000) analysed a sub-set of this work, examining female offenders
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 a
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 173 adults
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Petersilia 1992 a (Continued)
Interventions Community-based intensive supervision vs. routine parole/probation
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 b
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: No
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 115 adults
Interventions Community-based intensive supervision vs. routine parole/probation
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Petersilia 1992 c
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 58 adults
Interventions Community-based intensive supervision vs. routine parole/probation
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 d
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: No
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 53 adults
Interventions Community-based intensive supervision vs. routine parole/probation
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
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Petersilia 1992 d (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 e
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: No
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 50 adults
Interventions Community-based intensive supervision & increased surveillance vs. intensive supervision
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 f
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: No
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 50 adults
Interventions Community-based intensive supervision & increased surveillance vs. intensive supervision
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
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Petersilia 1992 f (Continued)
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Petersilia 1992 g
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: No
Blinding methodology: unknown
Loss to follow-up: unknown
Participants 50 adults
Interventions Community-based intensive supervision & increased surveillance vs. intensive supervision
Outcomes Recidivism for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for any offence (official records) during the last 12 months at 12 months follow-up
Arrest for a drug offence (official records) during the last 12 months at 12 months follow-up
Conviction (official records) during the last 12 months at 12 months follow-up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Rossman 1999
Methods Allocation: random assignment
Randomisation method: unclear. Similar on drug use: No
Similar on criminal activity: No
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 398 adults
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Rossman 1999 (Continued)
Interventions Community-based Opportunity to Succeed aftercare vs. routine parole/probation
Outcomes Marijuana use (self-report) during the last 12 months at 12 months follow-up
Marijuana use (self-report) during the last 3 months at 12 months follow-up
Intense marijuana use (self-report) during the last 12 months at 12 months follow-up
Hard drug use (self-report) during the last 12 months at 12 months follow-up
Hard drug use (self-report) during the last 3 months at 12 months follow-up
Intense hard drug use (self-report) during the last 12 months at 12 months follow-up
Drug dealing (self-report) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sacks 2004
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: no
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 236 adults
Mean age 34.3 (s.d. 8.8)
100% male
49% white
100% drug-using
32% alcohol-using
100% psychiatric history
Eligibility criteria: prisoners who have both a serious mental disorder and a substance use disorder
Interventions Secure establishment-based therapeutic community vs. treatment as usual.
(I) Personal Reflections therapeutic community & voluntary residential aftercare (n=142) vs. (C) mental
health program (n=94).
(I) therapeutic community included psycho-educational classes, cognitive behavioural methods, medica-
tion and group therapy. Activites were attended 5 days per week for 4 to 5 hours per day with the rest of
the day spent working in the prison; duration 12 months. (I) aftercare included mental health counselling,
medication and psychiatric services and basic skills. Activites were attended 3 to 7 days per week for 3 to 5
hours per day; duration 6 months. (C) program included intensive psychiatric services with medication,
weekly individual therapy and counselling and specialized groups of cognitive behavioural work, anger
management, therapy and education, domestic violence, parenting and weekly drug/alcohol therpay with
a 72-hour course on substance abuse education and relapse prevention; duration 12 months
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Sacks 2004 (Continued)
Outcomes Criminal activity regarding a new offence (official records) during the last 12 months at 12 months follow-
up
Incarceration for a new offence (official records) during the last 12 months at 12 months follow-up
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Wexler 1999
Methods Allocation: random assignment
Randomisation method: unclear
Similar on drug use: yes
Similar on criminal activity: yes
Blinding methodology: unknown
Loss to follow-up: adequate
Participants 715 adults
Mean age 30.9 (s.d. 7.4)
100% male
37.8% white
100% drug-using
Alcohol use not reported
100% psychiatric history
Eligibility criteria: offenders with a drug problem who were between 9 and 14 months from parole.
Offenders convicted of arson or sexual crimes to minors were not eligible
Interventions Secure establishment-based therapeutic community vs. no treatment.
(I) Amity TC & voluntary residential aftercare (n=x) vs. (C) waiting-list control (n=x).
(I) therapeutic community included a 2 to 3-month orientation phase, a 5 to 6-month treatment stage,
and a 1 to 3-month re-entry phase; total duration 12 months. (I) included need assessment, education,
group work, counselling and prison industry jobs. (I) aftercare duration up to 12 months. (C) duration
not applicable
Outcomes Incarceration (official records) during the last 12 months at 12 months follow-up
Incarceration (official records) during the last 24 months at 24 months follow-up
Incarceration (official records) during the last 36 months at 36 months follow-up
Incarceration (official records) during the last 60 months at 60 months follow-up
Drug use (self-report) during the last 60 months at 60 months follow-up
Notes
Risk of bias
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Wexler 1999 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Anglin 1999 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Dembo 2000 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods.
The follow-up periods reported for the different groups were not equivalent
Di Nitto 2002 The follow-up periods reported for the different groups were not equivalent
Dugan 1998 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Grohman 2002 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Harrell 2001 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Henggeler 1991 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Henggeler 2002 The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Messina 2000 The population of the study was not 100% drug using offenders that were specifically referred by the criminal
justice system to the intervention.
The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Nemes 1998 The population of the study was not 100% drug using offenders that were specifically referred by the criminal
justice system to the intervention.
The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
periods
Nemes 1999 The population of the study was not 100% drug using offenders that were specifically referred by the criminal
justice system to the intervention.
The study did not report relevant drug and/or crime outcome measures at both the pre and post intervention
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(Continued)
periods
Stevens 1998 The study did not include an appropriate comparison group.
The population of the study was not 100% drug using offenders that were specifically referred by the criminal
justice system to the intervention
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D A T A A N D A N A L Y S E S
Comparison 1. RCT Courts (Britt studies 3 & 4): pre-trial release & drugs testing & sanctions vs. routine pre-
trial release.
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Arrest at 90 days. 2 1124 Odds Ratio (M-H, Random, 95% CI) 1.33 [1.04, 1.70]
Comparison 2. RCT Secure Establishments (Sacks &Wexler): TC& aftercare vs. mental health program/waiting-
list control.
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Incarceration at 1 year. 2 854 Odds Ratio (M-H, Random, 95% CI) 0.37 [0.16, 0.87]
2 Incarceration at I year: sensitivity
analysis.
2 951 Odds Ratio (M-H, Random, 95% CI) 0.66 [0.38, 1.15]
Comparison 3. RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recidivism at 1 year. 4 399 Odds Ratio (M-H, Random, 95% CI) 1.98 [1.01, 3.87]
2 Arrest at 1 year. 4 399 Odds Ratio (M-H, Random, 95% CI) 1.49 [0.88, 2.51]
3 Drug arrest at 1 year. 4 399 Odds Ratio (M-H, Random, 95% CI) 1.10 [0.50, 2.39]
4 Conviction at 1 year. 4 399 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.55, 1.58]
5 Incarceration at 1 year. 4 399 Odds Ratio (M-H, Random, 95% CI) 0.88 [0.50, 1.54]
Comparison 4. RCT Community (Petersilia studies 5-7): int. supervision & increased surveillance vs. int. super-
vision.
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Recidivism at 1 year. 3 150 Odds Ratio (M-H, Random, 95% CI) 2.09 [0.86, 5.07]
2 Arrest at 1 year. 3 150 Odds Ratio (M-H, Random, 95% CI) 1.22 [0.51, 2.88]
3 Drug arrest at 1 year. 3 150 Odds Ratio (M-H, Random, 95% CI) 1.29 [0.35, 4.85]
4 Conviction at 1 year. 3 150 Odds Ratio (M-H, Random, 95% CI) 1.14 [0.22, 5.91]
5 Incarceration at 1 year. 3 150 Odds Ratio (M-H, Random, 95% CI) 1.30 [0.39, 4.30]
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Analysis 1.1. Comparison 1 RCT Courts (Britt studies 3 & 4): pre-trial release & drugs testing & sanctions
vs. routine pre-trial release., Outcome 1 Arrest at 90 days..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 1 RCT Courts (Britt studies 3 % 4): pre-trial release % drugs testing % sanctions vs. routine pre-trial release.
Outcome: 1 Arrest at 90 days.
Study or subgroup Testing%sanctions Routine release Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Britt 1992 c 30/118 28/116 16.9 % 1.07 [ 0.59, 1.94 ]
Britt 1992 d 193/425 174/465 83.1 % 1.39 [ 1.06, 1.82 ]
Total (95% CI) 543 581 100.0 % 1.33 [ 1.04, 1.70 ]
Total events: 223 (Testing%sanctions), 202 (Routine release)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.62, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 2.30 (P = 0.022)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 2.1. Comparison 2 RCT Secure Establishments (Sacks & Wexler): TC & aftercare vs. mental
health program/waiting-list control., Outcome 1 Incarceration at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 2 RCT Secure Establishments (Sacks % Wexler): TC % aftercare vs. mental health program/waiting-list control.
Outcome: 1 Incarceration at 1 year.
Study or subgroup TC % aftercare Comparison Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sacks 2004 7/75 21/64 37.5 % 0.21 [ 0.08, 0.54 ]
Wexler 1999 144/425 144/290 62.5 % 0.52 [ 0.38, 0.71 ]
Total (95% CI) 500 354 100.0 % 0.37 [ 0.16, 0.87 ]
Total events: 151 (TC % aftercare), 165 (Comparison)
Heterogeneity: Tau2 = 0.28; Chi2 = 3.22, df = 1 (P = 0.07); I2 =69%
Test for overall effect: Z = 2.27 (P = 0.023)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
36Interventions for drug-using offenders in the courts, secure establishments and the community. (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.2. Comparison 2 RCT Secure Establishments (Sacks & Wexler): TC & aftercare vs. mental
health program/waiting-list control., Outcome 2 Incarceration at I year: sensitivity analysis..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 2 RCT Secure Establishments (Sacks % Wexler): TC % aftercare vs. mental health program/waiting-list control.
Outcome: 2 Incarceration at I year: sensitivity analysis.
Study or subgroup TC % aftercare Comparison Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sacks 2004 74/142 51/94 42.8 % 0.92 [ 0.54, 1.55 ]
Wexler 1999 144/425 144/290 57.2 % 0.52 [ 0.38, 0.71 ]
Total (95% CI) 567 384 100.0 % 0.66 [ 0.38, 1.15 ]
Total events: 218 (TC % aftercare), 195 (Comparison)
Heterogeneity: Tau2 = 0.11; Chi2 = 3.39, df = 1 (P = 0.07); I2 =71%
Test for overall effect: Z = 1.46 (P = 0.14)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.1. Comparison 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine
parole/probation., Outcome 1 Recidivism at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome: 1 Recidivism at 1 year.
Study or subgroup ISP Parole/probation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 a 71/89 51/84 31.5 % 2.55 [ 1.30, 5.03 ]
Petersilia 1992 b 37/59 35/56 29.2 % 1.01 [ 0.47, 2.15 ]
Petersilia 1992 c 21/29 19/29 20.2 % 1.38 [ 0.45, 4.22 ]
Petersilia 1992 d 20/28 8/25 19.1 % 5.31 [ 1.64, 17.19 ]
Total (95% CI) 205 194 100.0 % 1.98 [ 1.01, 3.87 ]
Total events: 149 (ISP), 113 (Parole/probation)
Heterogeneity: Tau2 = 0.25; Chi2 = 6.68, df = 3 (P = 0.08); I2 =55%
Test for overall effect: Z = 2.00 (P = 0.046)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.2. Comparison 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine
parole/probation., Outcome 2 Arrest at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome: 2 Arrest at 1 year.
Study or subgroup ISP Parole/probation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 a 41/89 30/84 42.1 % 1.54 [ 0.83, 2.83 ]
Petersilia 1992 b 14/59 16/56 28.0 % 0.78 [ 0.34, 1.79 ]
Petersilia 1992 c 14/29 8/29 18.5 % 2.45 [ 0.82, 7.31 ]
Petersilia 1992 d 8/28 3/25 11.3 % 2.93 [ 0.68, 12.61 ]
Total (95% CI) 205 194 100.0 % 1.49 [ 0.88, 2.51 ]
Total events: 77 (ISP), 57 (Parole/probation)
Heterogeneity: Tau2 = 0.07; Chi2 = 3.96, df = 3 (P = 0.27); I2 =24%
Test for overall effect: Z = 1.50 (P = 0.13)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.3. Comparison 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine
parole/probation., Outcome 3 Drug arrest at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome: 3 Drug arrest at 1 year.
Study or subgroup ISP Parole/probation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 a 10/89 9/84 66.7 % 1.05 [ 0.41, 2.74 ]
Petersilia 1992 b 2/59 1/56 10.3 % 1.93 [ 0.17, 21.90 ]
Petersilia 1992 c 0/29 1/29 5.8 % 0.32 [ 0.01, 8.24 ]
Petersilia 1992 d 3/28 2/25 17.2 % 1.38 [ 0.21, 9.01 ]
Total (95% CI) 205 194 100.0 % 1.10 [ 0.50, 2.39 ]
Total events: 15 (ISP), 13 (Parole/probation)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.82, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.23 (P = 0.81)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.4. Comparison 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine
parole/probation., Outcome 4 Conviction at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome: 4 Conviction at 1 year.
Study or subgroup ISP Parole/probation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 a 17/89 17/84 50.1 % 0.93 [ 0.44, 1.97 ]
Petersilia 1992 b 9/59 12/56 30.9 % 0.66 [ 0.25, 1.71 ]
Petersilia 1992 c 5/29 4/29 13.8 % 1.30 [ 0.31, 5.44 ]
Petersilia 1992 d 3/28 1/25 5.2 % 2.88 [ 0.28, 29.64 ]
Total (95% CI) 205 194 100.0 % 0.93 [ 0.55, 1.58 ]
Total events: 34 (ISP), 34 (Parole/probation)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.61, df = 3 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.27 (P = 0.79)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.5. Comparison 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine
parole/probation., Outcome 5 Incarceration at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 3 RCT Community (Petersilia studies 1-4): intensive supervision vs. routine parole/probation.
Outcome: 5 Incarceration at 1 year.
Study or subgroup ISP Parole/probation Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 a 15/89 16/84 52.9 % 0.86 [ 0.40, 1.87 ]
Petersilia 1992 b 7/59 9/56 28.3 % 0.70 [ 0.24, 2.04 ]
Petersilia 1992 c 3/29 4/29 12.6 % 0.72 [ 0.15, 3.55 ]
Petersilia 1992 d 4/28 1/25 6.2 % 4.00 [ 0.42, 38.45 ]
Total (95% CI) 205 194 100.0 % 0.88 [ 0.50, 1.54 ]
Total events: 29 (ISP), 30 (Parole/probation)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.96, df = 3 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.46 (P = 0.64)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.1. Comparison 4 RCT Community (Petersilia studies 5-7): int. supervision & increased
surveillance vs. int. supervision., Outcome 1 Recidivism at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 4 RCT Community (Petersilia studies 5-7): int. supervision % increased surveillance vs. int. supervision.
Outcome: 1 Recidivism at 1 year.
Study or subgroup ISP % surveillance ISP Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 e 20/26 12/24 3.33 [ 0.99, 11.22 ]
Petersilia 1992 f 26/26 24/24 0.0 [ 0.0, 0.0 ]
Petersilia 1992 g 9/24 8/26 1.35 [ 0.42, 4.36 ]
Total (95% CI) 76 74 2.09 [ 0.86, 5.07 ]
Total events: 55 (ISP % surveillance), 44 (ISP)
Heterogeneity: Tau2 = 0.04; Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 1.63 (P = 0.10)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
43Interventions for drug-using offenders in the courts, secure establishments and the community. (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.2. Comparison 4 RCT Community (Petersilia studies 5-7): int. supervision & increased
surveillance vs. int. supervision., Outcome 2 Arrest at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 4 RCT Community (Petersilia studies 5-7): int. supervision % increased surveillance vs. int. supervision.
Outcome: 2 Arrest at 1 year.
Study or subgroup ISP % surveillance ISP Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 e 3/26 1/24 13.6 % 3.00 [ 0.29, 31.01 ]
Petersilia 1992 f 11/26 9/24 57.7 % 1.22 [ 0.39, 3.80 ]
Petersilia 1992 g 3/24 4/26 28.6 % 0.79 [ 0.16, 3.94 ]
Total (95% CI) 76 74 100.0 % 1.22 [ 0.51, 2.88 ]
Total events: 17 (ISP % surveillance), 14 (ISP)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.86, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.66)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.3. Comparison 4 RCT Community (Petersilia studies 5-7): int. supervision & increased
surveillance vs. int. supervision., Outcome 3 Drug arrest at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 4 RCT Community (Petersilia studies 5-7): int. supervision % increased surveillance vs. int. supervision.
Outcome: 3 Drug arrest at 1 year.
Study or subgroup ISP % surveillance ISP Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 e 2/26 0/24 18.3 % 5.00 [ 0.23, 109.62 ]
Petersilia 1992 f 3/26 3/24 59.9 % 0.91 [ 0.17, 5.03 ]
Petersilia 1992 g 1/24 1/26 21.8 % 1.09 [ 0.06, 18.40 ]
Total (95% CI) 76 74 100.0 % 1.29 [ 0.35, 4.85 ]
Total events: 6 (ISP % surveillance), 4 (ISP)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.93, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.4. Comparison 4 RCT Community (Petersilia studies 5-7): int. supervision & increased
surveillance vs. int. supervision., Outcome 4 Conviction at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 4 RCT Community (Petersilia studies 5-7): int. supervision % increased surveillance vs. int. supervision.
Outcome: 4 Conviction at 1 year.
Study or subgroup ISP % surveillance ISP Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 e 2/26 0/24 5.00 [ 0.23, 109.62 ]
Petersilia 1992 f 5/26 6/24 0.71 [ 0.19, 2.74 ]
Petersilia 1992 g 0/24 0/26 0.0 [ 0.0, 0.0 ]
Total (95% CI) 76 74 1.14 [ 0.22, 5.91 ]
Total events: 7 (ISP % surveillance), 6 (ISP)
Heterogeneity: Tau2 = 0.46; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.16 (P = 0.88)
0.1 0.2 0.5 1 2 5 10
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46Interventions for drug-using offenders in the courts, secure establishments and the community. (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.5. Comparison 4 RCT Community (Petersilia studies 5-7): int. supervision & increased
surveillance vs. int. supervision., Outcome 5 Incarceration at 1 year..
Review: Interventions for drug-using offenders in the courts, secure establishments and the community.
Comparison: 4 RCT Community (Petersilia studies 5-7): int. supervision % increased surveillance vs. int. supervision.
Outcome: 5 Incarceration at 1 year.
Study or subgroup ISP % surveillance ISP Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Petersilia 1992 e 2/26 1/24 23.6 % 1.92 [ 0.16, 22.61 ]
Petersilia 1992 f 4/26 4/24 62.8 % 0.91 [ 0.20, 4.13 ]
Petersilia 1992 g 1/24 0/26 13.6 % 3.38 [ 0.13, 87.11 ]
Total (95% CI) 76 74 100.0 % 1.30 [ 0.39, 4.30 ]
Total events: 7 (ISP % surveillance), 5 (ISP)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.64, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.67)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
A D D I T I O N A L T A B L E S
Table 1. MEDLINE
MEDLINE search
1. exp “Substance-Related-Disorders”/
2. ((drug or substance) adj (abuse* or addict* or dependen* or misuse*)).ti,ab
3. (drug* adj (treat* or intervention* or program*)
4. substance near (treat* or intervention* or program*)
5.(detox* or methadone) in ti,ab
6. narcotic* near (treat* or intervention* or program*)
7. 1 or 2 or 3 or 4 or 5 or 6
8. prison*. ti,ab
9. exp “Prisoners”/
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Table 1. MEDLINE (Continued)
10. offender* or criminal* or inmate* or convict* or probation* or remand or felon*).ti,ab
11. exp “Prisons”/
12. 8 or 9 or 10 or 11
13. 7 and 12
Table 2. EMBASE
Embase search
1. (detox$ or methadone or antagonist prescri$).ti,ab.
2. detoxification/ or drug detoxification/ or drug withdrawal/ or drug dependence treatment/ or methadone/ ormethadone treatment/
or diamorphine/ or naltrexone/
3. (diamorphine or naltrexone or therapeutic communit$).ti,ab
4. morality/
5. (motivational interview$ or motivational enhancement).ti,ab
6. (counselling or counseling).ti,ab.
7. exp counseling/
8. (psychotherap$ or cognitive behavioral or cognitive behavioural).ti,ab
9. exp psychotherapy/
10. (moral adj3 training).ti,ab.
11. (cognitive restructuring or assertiveness training).ti,ab
12. reinforcement/ or self monitoring/ or self control/
13. (relaxation training or rational emotive or family relationship therap$).ti,ab
14. social learning/ or withdrawal syndrome/ or coping behavior/
15. (community reinforcement or self monitoring or self control or self management or interpersonal skills).ti,ab
16. (goal$ adj3 setting).ti,ab.
17. (social skills adj3 training).ti,ab.
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Table 2. EMBASE (Continued)
18. anger/ or lifestyle/
19. (basic skills adj3 training).ti,ab.
20. (relapse adj3 prevent$).ti,ab.
21. (craving adj3 (minimi$ or reduc$)).ti,ab.
22. (trigger or triggers or coping skills or anger management or group work).ti,ab
23. (lifestyle adj3 modifi$).ti,ab.
24. (high intensity training or resettlement or throughcare or aftercare or after care).ti,ab
25. aftercare/ or halfway house/
26. (brief solution or brief intervention$ or minnesota program$ or 12 step$ or twelve step$).ti,ab
27. (needle exchange or nes or syringe exchange or dual diagnosis or narcotics anonymous).ti,ab
28. self help/ or support group/
29. (self-help or selfhelp or self help or outreach or bail support or arrest referral$).ti,ab
30. exp urinalysis/ or rehabilitation/ or rehabilitation center/
31. (diversion or dtto or dttos or drug treatment or testing order$ or carat or carats).ti,ab
32. (combined orders or drug-free or drug free).ti,ab.
33. (peer support or evaluation$ or urinalysis or drug testing or drug test or drug tests).ti,ab
34. ((rehab or rehabilitation or residential or discrete) adj2 (service$ or program$)).ti,ab
35. (asro or addressing substance$ or pasro or prisons addressing or acupuncture or shock or boot camp or boot camps).ti,ab
36. (work ethic camp$ or drug education or tasc or treatment accountability).ti,ab
37. exp acupuncture/
38. or/1-36
39. (remand or prison or prisoner or prisoners or offender$ or criminal$ or probation or court or courts).ti,ab
40. (secure establishment$ or secure facilit$).ti,ab.
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Table 2. EMBASE (Continued)
41. (reoffend$ or reincarcerat$ or recidivi$ or ex-offender$ or jail or jails or goal or goals).ti,ab
42. (incarcerat$ or convict or convicts or convicted or felon or felons or conviction$ or revocation or inmate$ or high security).ti,ab
43. criminal justice/ or custody/ or detention/ or prison/ or prisoner/ or offender/ or probation/ or court/ or recidivism/ or crime/ or
criminal behavior/ or punishment/
44. or/39-43
45. 38 and 44
46. (substance abuse$ or substance misuse$ or substance use$).ti,ab
47. (drug dependanc$ or drug abuse$ or drug use$ or drug misuse$ or drug addict$).ti,ab
48. (narcotics adj3 (addict$ or use$ or misuse$ or abuse$)).ti,ab
49. (chemical dependanc$ or opiates or heroin or crack or cocaine or amphetamines or addiction or dependance disorder or drug
involved).ti,ab
50. substance abuse/ or drug abuse/ or analgesic agent abuse/ or drug abuse pattern/ or drug misuse/ or intravenous drug abuse/ or
multiple drug abuse/
51. addiction/ or drug dependence/ or narcotic dependence/ or exp narcotic agent/ or narcotic analgesic agent/
52. opiate addiction/ or heroin dependence/ or morphine addiction/
53. cocaine/ or amphetamine derivative/ or psychotropic agent/
54. or/46-53
55. 45 and 54
56. limit 55 to yr=1980-2004
Table 3. PsycInfo
PsycInfo
1. (detoxification in de) or (drug withdrawal in de)
2. (drug usage screening in de) or (methadone maintenance) in de
3. explode “Narcotic-Antagonists” in DE
4. 1 or 2 or 3
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Table 3. PsycInfo (Continued)
5. (counseling in de) or (explode “psychotherapeutic-counseling” in de)
6. (explode “cognitive-therapy” in de) or (explode “psychotherapeutic-techniques” in de)
7. (cognitive restructuring in de) or (assertiveness training in de)
8. explode “relaxation-therapy” in de
9. (rational emotive therapy in de) or (rational-emotive therapy in de)
10. (explode “self monitoring” in de) or (explode self-monitoring) in de
11. (goal setting in de) or (self control in de) or (explode “self-management” in de)
12. (social skills in de) or (relapse prevention in de) or (craving in de) or (coping behavior in de)
13. (anger control in de) or (explode “group-psychotherapy” in de) or (brief psychotherapy in de)
14. (explode “behavior-modification” in de) or (posttreatment followup in de) or (aftercare in de)
15. (halfway houses in de) or (twelve step programs in de)
16. (dual diagnoses in de) or (explode “self help techniques” in de) or (outreach programs in de) or (court referrals in de)
17. (peer pressure in de) or (urinalysis in de)
18. (drug rehabilitation in de) or (residential care institutions in de) or (acupuncture in de) or (drug education in de)
19. (detox* or methadone or antagonist prescri* or diamorphine or naltrexone or therapeutic communit*) in ti,ab
20. (motivational interview* or motivational enhancemen* or counseling or psychotherapy or psychotherapies) in ti,ab
21. (cognitive behav* or cognitive therapy or cognitive therapies or moral training or cognitive restructuring) in ti,ab
22. (assertiveness training or relaxation training or relaxation therapy or relaxation therapies) in ti,ab
23. (rational emotive therap* or rational emotive behav* therap* or family relationship therap* or community reinforcement) in ti,ab
24. (self-monitor* or self monitor* or goal setting or self control or self-control or self management or self-management) in ti,ab
25. (interpersonal skills training or social skills training or basic skills training) in ti,ab
26. (relapse with prevent*) in ti,ab
27. (craving near reduc*) in ti,ab
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Table 3. PsycInfo (Continued)
28. craving with (reduc* in ti,ab)
29. (trigger* or coping skills or anger management or group work or lifestyle modif* or high intensity training or resettlement) in ti,
ab
30. (throughcare or aftercare or after care or brief solution* or brief intervention*) in ti,ab
31. (minnesota or 12 step* or twelve step* or needle exchange or nes or syringe exchange or dual diagnosis) in ti,ab
32. (narcotics anonymous or self-help or self help or outreach or bail support or arrest referral*) in ti,ab
33. (diversion or dtto* or testing order* or carat* or counseling assessment referral or combined order or combined orders or drug
free wing* or drug free environment*) in ti,ab
34. (peer support or user evaluations or urinalysis or urinalyses or mandatory drug test* or rehabilitation or discrete service* or discrete
program*) in ti,ab
35. (residential program* or residential scheme* or asro or addressing substance* or pasro or prisons addressing substance) in ti,ab
36. (acupuncture or shock or boot camp* or work ethic or drug education or tasc or treatment accountability) in ti,ab
37. or/4-36
38. (secure facilities or convict* or revocation or inmate* or high security) in ti,ab
39. (prisoners in de) or (explode “correctional-institutions” in de)
40. (perpetrators in de) or (explode criminals in de)
41. (probation in de) or (parole in de) or (incarceration in de) or (recidivism in de) or (criminal conviction in de) or (crime in de)
42. (remand or prison* or offender* or criminal* or probation or court or courts or secure establishment* or reoffend* or reincarcerat*
or recidivi* or ex-offender* or jail or jails or incarcerat*) in ti,ab
43. (drug abuse in de) or (explode “inhalant-abuse” in de) or (explode “drug-dependency” in de)
44. (polydrug abuse in de) or (drug abuse in de) or (intravenous drug usage in de)
45. (narcotic drugs in de) or (heroin in de) or (cocaine in de) or (explode amphetamine in de)
46. (substance abuse* or substance misuse* or substance user*) in ti,ab
47. (drug dependen* or drug abuse* or drug misuse* or drug addict* or drug use) in ti,ab
48. (narcotic abuse* or narcotic misuse* or chemical dependen* or opiate misuse* or opiate abuse*) in ti,ab
49. (heroin use* or heroin addict* or heroin misuse* or heroin abuse*) in ti,ab
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Table 3. PsycInfo (Continued)
50. (crack use* or crack addict* or crack misuse* or crack abuse*) in ti,ab
51. (cocaine use* or cocaine addict* or cocaine misuse* or cocaine abuse*) in ti,ab
52. (amphetamine* use* or amphetamine* addict* or amphetamine* misuse* or amphetamine* abuse*) in ti,ab
53. (dependence disorder or drug involved or dug-involved) in ti,ab
54. #38 or #39 or #40 or #41 or #42
55. #4 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53
56. #37 and #54 and #55
Table 4. SPECTRA
SPECTRA search
1. {remand} or {prison} or {offender} or {criminal} or {probation} or {court} or {tribunal} or {secure establishment} or {secure facilit} or
{reoffend} or {reincarcerat} or {recidivi} or {ex-offender} or {jail} or {incarcerat} or {convict} or {felon} or {reconvict} or {high security}
or {law enforcement}
{remand} or {prison} or {offender} or {criminal} or {probation} or {court} or {tribunal} or {secure establishment} or {secure facilit} or
{reoffend} or {reincarcerat} or {recidivi} or {ex-offender} or {jail} or {incarcerat} or {convict} or {felon} or {reconvict} or {high security}
or {law enforcement}
2. {substance} or {dependenc} or {drug abuse} or {drug use} or {drug misuse} or {addict}
All indexed fields: {remand} or {prison} or {offender} or {criminal} or {probation} or {court} or {tribunal} or {secure establishment} or
{secure facilit} or {reoffend} or {reincarcerat} or {recidivi} or {ex-offender} or {jail} or {incarcerat} or {convict} or {felon} or {reconvict}
or {high security} or {law enforcement}
OR
All unindexed fields: {remand} or {prison} or {offender} or {criminal} or {probation} or {court} or {tribunal} or {secure establishment}
or {secure facilit} or {reoffend} or {reincarcerat} or {recidivi} or {ex-offender} or {jail} or {incarcerat} or {convict} or {felon} or {reconvict}
or {high security} or {law enforcement}
AND
All unindexed fields: {substance} or {dependenc} or {drug abuse} or {drug use} or {drug misuse} or {addict} or {narcotics} or {opiates}
or {heroin} or {crack} or {cocaine} or {amphetamines} or {drug involved} or {substance-related} or {amphetamine-related} or {cocaine-
related} or {marijuana} or {opioid} or {street drug} or {designer drug}
3. narcotics
4. opiates
5. heroin
6. {crack}
7. cocaine
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Table 4. SPECTRA (Continued)
8. amphetamines
9. drug involved
10. substance-related
11. amphetamine-related
12. cocaine-related
13. marijuana
14. opioid
15. street drug
16. designer drug
17. 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18. 1 AND 17
Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr
PASCAL search
1. (DETOX? OR METHADONE OR ANTAGONIST()PRESCRI?)/TI,AB
2. METHADONE/DE OR NALTREXONE/DE
3. (DIAMORPHINE OR NALTREXONE)/TI,AB
4. THERAPEUTIC()COMMUNITY/DE OR THERAPEUTIC()COMMUNIT?)/TI,AB
5. (MOTIVATIONAL()INTERVIEW? ORMOTIVATIONAL()ENHANCEMENT)/TI,AB
6. (COUNSELLING OR COUNSELING)/TI,AB
7. COUNSELING/DE
8. (PSYCHOTHERAP? OR COGNITIVE()BEHAVIORAL OR COGNITIVE()BEHAVIOURAL)/TI,AB
9. PSYCHOTHERAPY!/DE
10. (MORAL(3W)TRAINING)/TI,AB
11. (COGNITIVE()RESTRUCTURING OR ASSERTIVENESS()TRAINING)/TI,AB
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Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr (Continued)
12. ASSERTIVENESS/DE OR RELAXATION()TECHNIQUES/DE
13. (RELAXATION()TRAINING OR RATIONAL()EMOTIVE OR FAMILY()RELATIONSHIP()THERAP?)/TI,AB
14. FAMILY()RELATIONS/DE
15. (COMMUNITY()REINFORCEMENT OR SELF()MONITORING OR SELF()CONTROL OR SELF()MANAGEMENT
OR INTERPERSONAL()SKILLS)/TI,AB
16. (GOAL?(3W)SETTING)/TI,AB
17. (SOCIAL(3W)TRAINING)/TI,AB
18. SOCIAL RESPONSIBILITY/DE
19. (BASIC()SKILLS(3W)TRAINING)/TI,AB
20. (RELAPSE(3W)PREVENT?)/TI,AB
21. (CRAVING(3W)(MINIMI? OR REDUC?))/TI,AB
22. (TRIGGER OR TRIGGERS OR COPING()SKILLS OR ANGER()MANAGEMENT OR GROUP()WORK)/TI,AB
23. (LIFESTYLE(3W)MODIFI?)/TI,AB
24. (HIGH()INTENSITY()TRAININGORRESETTLEMENTORTHROUGHCARE ORAFTERCAREORAFTER()CARE)
/TI,AB
25. ADAPTATION,-PSYCHOLOGICAL!/DE OR ANGER/DE OR LIFE()STYLE/DE OR AFTER()CARE/DE ORHALFWAY
()HOUSES/DE
26. (BRIEF()SOLUTION OR BRIEF()INTERVENTION? OR MINNESOTA()PROGRAM? OR 12()STEP? OR TWELVE()
STEP?)/TI,AB
27. (NEEDLE()EXCHANGE OR NES OR SYRINGE()EXCHANGE OR DUAL()DIAGNOSIS OR NARCOTICS()ANONY-
MOUS)/TI,AB
28. NEEDLE-EXCHANGE()PROGRAMS/DE
29. (SELF-HELP OR SELFHELP OR SELF()HELP OR OUTREACH OR BAIL()SUPPORT OR ARREST()REFERRAL?)/TI,
AB
30. SELF-HELP()GROUPS/DE OR URINALYSIS/DE OR SUBSTANCE()ABUSE()DETECTION/DE
31. (DIVERSION ORDTTO ORDTTOS ORDRUG()TREATMENT OR TESTING()ORDER? ? OR CARAT OR CARATS)
/TI,AB
32. (COMBINED()ORDERS OR DRUG-FREE OR DRUG()FREE)/TI,AB
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Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr (Continued)
33. (PEER()SUPPORT OR EVALUATION? ? OR URINALYSIS OR DRUG()TESTING OR DRUG()TEST? ?)/TI,AB
34. ((REHAB OR REHABILITATION OR RESIDENTIAL OR DISCRETE)(2W)(SERVICE? ? OR PROGRAM?))/TI,AB
35. (ASROORADDRESSING()SUBSTANCE?ORPASROORPRISONS()ADDRESSINGORACUPUNCTUREORSHOCK
OR BOOT()CAMP OR BOOT()CAMPS)/TI,AB
36. (WORK()ETHIC()CAMP? ? OR DRUG()EDUCATION OR TASC OR TREATMENT()ACCOUNTABILITY)/TI,AB
37. ACUPUNCTURE-THERAPY!/DE OR ACUPUNCTURE/DE OR HEALTH()EDUCATION/DE OR SUBSTANCE()
ABUSE()TREATMENT()CENTERS/DE
38. S1:S3
39. S4:S37
40. S38 AND S39
40. (REMAND OR PRISON OR PRISONER OR PRISONERS OR OFFENDER? ? OR CRIMINAL? ? OR PROBATION OR
COURT OR COURTS)/TI,AB
41. (SECURE()ESTABLISHMENT? ? OR SECURE()FACILIT?)/TI,AB
42. (REOFFEND? OR REINCARCERAT? OR RECIDIVI? OR EX()OFFENDER? ? OR JAIL OR JAILS)/TI,AB
43. (INCARCERAT? OR CONVICT OR CONVICTS OR CONVICTED OR FELON? ? OR CONVICTION? ? OR REVO-
CATION OR INMATE? ? OR HIGH()SECURITY)/TI,AB
44. PRISONERS/DE OR LAW()ENFORCEMENT/DE OR JURISPRUDENCE/DE
45. S40:S44
46. S40 AND S45
47. (SUBSTANCE()ABUSE? OR SUBSTANCE()MISUSE? OR SUBSTANCE()USE?)/TI,AB
48. (DRUG()DEPENDANC? OR DRUG()ABUSE? OR DRUG()USE? OR DRUG()MISUSE? OR DRUG()ADDICT?)/TI,AB
49. (NARCOTICS(3W)(ADDICT? OR USE? OR MISUSE? OR ABUSE?))/TI,AB
50. (CHEMICAL()DEPENDANC? OR OPIATES OR HEROIN OR CRACK OR COCAINE OR AMPHETAMINES OR
ADDICTION OR DEPENDENCE()DISORDER OR DRUG()INVOLVED)/TI,AB
51. SUBSTANCE-RELATED()DISORDERS/DE OR AMPHETAMINE-RELATED()DISORDERS/DE OR COCAINE-RE-
LATED()DISORDERS/DE OR MARIJUANA ()ABUSE/DE
52. OPIOID-RELATED-DISORDERS!/DE OR PHENCYCLIDINE()ABUSE/DE OR SUBSTANCE()ABUSE()INTRA-
VENOUS/DE
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Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr (Continued)
53. STREET()DRUGS/DE OR DESIGNER()DRUGS/DE OR NARCOTICS/DE
54. COCAINE!/DE OR AMPHETAMINES!/DE OR ANALGESICS()OPIOID/DE
55. S47:S54
56. S46 AND S55
57. (DETOXIFICATION OR METHADONE OR ANTAGONIST-PRESCRIBING)/DE FROM 144,34,434,7,99,65,35,6
58. (DIAMORPHINE OR NALTREXONE)/DE FROM 144,34,434,7,99,65,35,6
59. THERAPEUTIC-COMMUNITY)/DE FROM 144,34,434,7,99,65,35,6
60. (MOTIVATIONAL-INTERVIEW OR MOTIVATIONAL-ENHANCEMENT)/DE FROM 144,34,434,7,99,65,35,6
61. (COUNSELLING OR COUNSELING)/DE FROM 144,34,434,7,99,65,35,6
62. (PSYCHOTHERAPY! OR COGNITIVE-BEHAVIORAL OR COGNITIVE-BEHAVIOURAL)/DE FROM 144,34,434,7,
99,65,35,6
63. (MORAL-TRAINING)/DE FROM 144,34,434,7,99,65,35,6
64. (COGNITIVE-RESTRUCTURING OR ASSERTIVENESS-TRAINING)/DE FROM 144,34,434,7,99,65,35,6
65. (RELAXATION-TRAINING OR RATIONAL-EMOTIVE OR FAMILY-RELATIONSHIP-THERAPY)/DE FROM 144,34,
434,7,99,65,35,6
66. FAMILY-RELATIONS/DE
67. (COMMUNITY-REINFORCEMENT OR SELF-MONITORING OR SELF-CONTROL OR SELF-MANAGEMENTOR
INTERPERSONAL-SKILLS)/DE FROM 44,34,434,7,99,65,35,6
68. (GOAL-SETTING)/DE FROM 144,34,434,7,99,65,35,6
69. (SOCIAL-SKILLS-TRAINING)/DE FROM 144,34,434,7,99,65,35,6
70. SOCIAL-RESPONSIBILITY/DE
71. (BASIC-SKILLS-TRAINING)/DE FROM 144,34,434,7,99,65,35,6
72. (RELAPSE-PREVENTION)/DE FROM 144,34,434,7,99,65,35,6
73. CRAVING/DE FROM 144,34,434,7,99,65,35,6
74. (TRIGGER OR COPING-SKILLS OR ANGER-MANAGEMENT OR GROUP-WORK)/DE FROM 144,34,434,7,99,65,
35,6
75. (LIFESTYLE-MODIFICATION)/DE FROM 144,34,434,7,99,65,35,6
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Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr (Continued)
76. (HIGH-INTENSITY-TRAINING OR RESETTLEMENT OR THROUGHCARE OR AFTERCARE OR AFTER-CARE)/
DE FROM 144,34,434,7,99,65,35,6
77. (BRIEF-SOLUTION OR BRIEF-INTERVENTIONS OR MINNESOTA-PROGRAM OR 12-STEP-PROGRAM OR
TWELVE-STEP-PROGRAM)/DE FROM 144,34,434,7,99,65,35,6
77. (NEEDLE-EXCHANGE OR SYRINGE-EXCHANGE OR DUAL-DIAGNOSIS OR NARCOTICS-ANONYMOUS)/DE
FROM 144,34,434,7,99,65,35,6
79. (SELF-HELP OR OUTREACH OR BAIL-SUPPORT OR ARREST-REFERRAL)/DE FROM 144,34,434,7,99,65,35,6
80. (DRUG-TREATMENT OR TESTING-ORDERS OR CARAT)/DE FROM 144,34,434,7,99,65,35,6
81. (COMBINED-ORDERS OR DRUG-FREE)/DE FROM 144,34,434,7,99,65,35,6
82. (PEER-SUPPORT OR EVALUATION OR URINALYSIS OR DRUG-TESTING OR DRUG-TESTS)/DE FROM 144,34,
434,7,99,65,35,6
83. (REHABILITATION OR RESIDENTIAL OR DISCRETE-SERVICES)/DE FROM 144,34,434,7,99,65,35,6
84. (ASRO OR PASRO ACUPUNCTURE OR BOOT-CAMP)/DE FROM 144,34,434,7,99,65,35,6
85. (WORK-ETHIC-CAMP OR DRUG-EDUCATION OR TASC OR TREATMENT-ACCOUNTABILITY)/DE FROM 144,
34,434,7,99,65,35,6
86. (REMAND OR PRISON OR PRISONER OR PRISONERS OR OFFENDER OR OFFENDERS OR CRIMINAL OR
CRIMINALS OR PROBATION OR COURT OR COURTS)/DE FROM 144,34,434,7,99,65,35,6
87. (SECURE-ESTABLISHMENTS OR SECURE-FACILITY)/DE FROM 144,34,434,7,99,65,35,6
88. (REOFFENDERS OR REINCARCERATION OR RECIDIVISM OR EX-OFFENDERS OR JAILS)/DE FROM 144,34,
434,7,99,65,35,6
89. (INCARCERATIONORCONVICTORCONVICTSORFELONORFELONSORCONVICTIONSORREVOCATION
OR INMATE OR INMATES OR HIGH-SECURITY)/DE FROM 144,34,434,7,99,65,35,6
90. (SUBSTANCE-ABUSE OR SUBSTANCE-MISUSE OR SUBSTANCE-USE)/DE FROM 144,34,434,7,99,65,35,6
91. (DRUG-DEPENDANCEORDRUG-DEPENDENCYORDRUG-ABUSEORDRUG-MISUSEORDRUG-ADDICT OR
DRUG-ADDICTION)/DE FROM 144,34,434,7,99,65,35,6
92. (CHEMICAL-DEPENDANCY OR OPIATE-DEPENDENCY OR HEROIN-DEPENDENCY OR CRACK-DEPEN-
DENCY OR COCAINE-DEPENDENCY OR AMPHETAMINES OR ADDICTION OR DEPENDENCE-DISORDER OR
DRUG-INVOLVED)/DE FROM 144,34,434,7,99,65,35,6
93. S40 OR S57:S85
94. S45 OR S86:S89
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Table 5. PASCAL, SciSearch, Social SciSearch, Wilson Applied Science and Technology Abstr (Continued)
95. S55 OR S90:S92
96. S93 AND S94 AND S95
97. S96/1980-2004
Table 6. The CENTRAL Register of Controlled Trials
CENTRAL search
1. prison*
2. offender*
3. (criminal* or probation or court*)
4. (secure next establishment*)
5. reoffend*
6. reincarcerat*
7. recidiv*
8. exoffend*
9. (jail or jails or incarcerat*)
10. (secure next facilit*)
10(secure next facilit*)
11. (convict* or revocation or inmate* or (high next security))
12. PRISONERS
13. LAW ENFORCEMENT
14. JURISPRUDENCE
15. CRIME
16. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
17. SUBSTANCE-RELATED DISORDERS
18. ((substance or drug*) next (abuse* or misuse* or dependen*or use* or addict*))
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Table 6. The CENTRAL Register of Controlled Trials (Continued)
19. (narcotics or chemical or opiate) next (dependen* or addict* or abuse* or misuse*))
20. ((heroin) next (addict* or dependen* or misuse* or abuse*))
21. ((crack) next (addict* or dependen* or misuse* or abuse* or use*))
22. ((cocaine next addict*) or (cocaine next dependenc*) or (cocaine next misuse*) or (cocaine next abuse*) or (cocaine next use*))
23. ((amphetamine*) next (addict* or dependen* or misuse* or abuse* or use*))
24. (addicts or (dependence next disorder) or (drug next involved))
25. (street next drugs)
26. STREET DRUGS
27. DESIGNER DRUGS
28. NARCOTICS
29. COCAINE
30. AMPHETAMINES
31. ANALGESICS ADDICTIVE
32. ANALGESICS OPIOID
33. PSYCHOTROPIC DRUGS
34. opioid* or opiat*
35. #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34
35. (#16 and #35)
Table 7. SIGLE
SIGLE
1. ((reoffend* or reincarcerat* or recidivi* or ex-offend* or jail or jails or incarcerat* or secure facilit* or convict* or revocation or
inmate*) in ti,ab)
2. ((remand or prison* or offender* or criminal* or probation or court or courts or secure establishment*) in ti,ab
3. ((drug dependenc* or drug addict* or narcotics abuse* or narcotics use* or narcotics misuse* or narcotics addict*) in ti,ab
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Table 7. SIGLE (Continued)
4. ((drug abuse* or drug misuse* or drug use*) in ti,ab
5. ((substance abuse* or substance misuse* or substance use*) in ti,ab
6. ((detox* or methadone maintenance or methadone prescri* or antagonist prescri* or dimorphine or naltrexone) in ti,ab
7. ((dependence disorder or drug involved) in ti,ab
8. ((amphetamine* abuse* or amphetamine* misuse* or amphetamine* use* or amphetamine* addict*) in ti,ab
9. ((cocaine abuse* or cocaine misuse* or cocaine use* or cocaine addict*) in ti,ab
10. ((crack abuse* or crack misuse* or crack use* or crack addict*) in ti,ab
11. ((heroin abuse* or heroin misuse* or heroin use* or heroin addict*) in ti,ab
12. ((chemical dependenc* or opiate abuse* or opiate misuse* or opiate use* or opiate addict*) in ti,ab
13. #1 or #2
14. #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12
15. #13 and #14
Table 8. Sociological Abstracts
Sociological Abstrac
1. remand in de
2. detention in de
3. prisoners in de
4. prisons in de
5. offenders in de
6. parole in de
7. probation in de
8. correctional system in de
9. courts in de
10. imprisonment in de
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Table 8. Sociological Abstracts (Continued)
11. criminal justice in de
12. criminal proceedings in de
13. recidivism in de
14. jail in de
15. institutionalization (persons) in de
16. conviction/convictions in de
17. (remand or prison* or offender* or criminal* or probation or court or courts or secure establishment*) in ti,ab
18. (reoffend* or reincarcerat* or recidivi* or ex-offend* or jail or jails or incarcerat* or secure facilit* or convict* or revocation or
inmate*) in ti,ab
19. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19
20. substance abuse in de
21. explode “Drug-Abuse” in DE
22. “Drug-Injection” in DE
23. explode “Narcotic-Drugs” in DE
24. “Cocaine-” in DE
25. “Addiction-” in DE
26. explode “Psychedelic-Drugs” in DE
27. (substance abuse* or substance misuse* or substance use*) in ti,ab
28. (drug abuse* or drug misuse* or drug use*) in ti,ab
29. (drug dependenc* or drug addict* or narcotics abuse* or narcotics use* or narcotics misuse* or narcotics addict*) in ti,ab
30. (chemical dependenc* or opiate abuse* or opiate misuse* or opiate use* or opiate addict*) in ti,ab
31. (heroin abuse* or heroin misuse* or heroin use* or heroin addict*) in ti,ab
32. (crack abuse* or crack misuse* or crack use* or crack addict*) in ti,ab
33. (cocaine abuse* or cocaine misuse* or cocaine use* or cocaine addict*) in ti,ab
34. (amphetamine* abuse* or amphetamine* misuse* or amphetamine* use* or amphetamine* addict*) in ti,ab
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Table 8. Sociological Abstracts (Continued)
35. (dependence disorder or drug involved) in ti,ab
36. #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35
37. #19 and #36
38. “Detoxification-” in DE
39. “Methadone-Maintenance” in DE
40. “Counseling-” in DE
41. “Psychotherapy-” in DE
42. “Assertiveness-” in DE
43. (detoxification in de) or (methadone maintenance in de) or (treatment programs in de)
44. (counseling in de) or (psychotherapy in de) or (assertiveness in de) or (group therapy in de) or (goals in de) or (self control in de)
45. (interpersonal communication in de) or (social interaction in de) or (social competence in de) or (coping in de)
46. (social behavior in de) or (group work in de) or (lifestyle in de)
47. (after care in de) or (support networks in de) or (self help in de) or (self help groups in de) or (outreach programmes in de)
48. (outreach programs in de) or (referral in de) or (delinquency prevention in de) or (diversion/diversions in de)
49. (peer groups in de) or (peer influence in de) or (drug use screening in de) or (rehabilitation in de) or (work experience in de)
50. (detox* or methadone maintenance or methadone prescri* or antagonist prescri* or dimorphine or naltrexone) in ti,ab
51. (therapeutic communit* or motivational interview* or motivational enhance* or counseling or counselling or psychotherapy or
cognitive behavi*) in ti,ab
52. (moral training or cognitive restructuring or assertiveness training or relaxation training) in ti,ab
53. (rational-emotive or rational emotive or family relationship therap* or community reinforcement or self monitoring or goal setting
or self control training) in ti,ab
54. (self management or interpersonal skills or social skills or basic skills or relapse prevent* or prevent* relapse or craving reduc* or
reduc* craving) in ti,ab
55. (trigger* or coping skills or anger management or group work or lifestyle modif* or high intensity training or resettlement or
throughcare) in ti,ab
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Table 8. Sociological Abstracts (Continued)
56. (aftercare or after care or brief solution or brief intervention* or 12 step* or twelve step* or minnesota program* or needle exchange
or nes) in ti,ab
57. (syringe exchange or dual diagnosis or narcotics anonymous or self help or selfhelp or outreach or bail support) in ti,ab
58. (arrest referral* or diversion or dtto or dttos or drug treatment or carat or carats or counseling assessment or combined orders) in
ti,ab
59. (drug-free or drug free or peer support or evaluation* or urinalysis or drug testing or drug use screen* or rehabilitation or discrete
service* or discrete program*) in ti,ab
60. (residential program* or residential scheme* or residential service*) in ti,ab
61. (asro or addressing substance or pasro or prisons addressing or acupuncture or shock or boot camp*) in ti,ab
62. (work ethic or drug education or tasc or treatment accountability) in ti,ab
63. #38 or #39 #or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #
55 or #56 or #57 or #58 or #59 or #60 or #61 or #62
64. #37 and #63
Table 9. ASSIA
ASSIA search
1. remand
2. prison or prisoner or prisoners
3. offender*
4. criminal*
5. probation
6. court or courts
7. tribunal or tribunals
8. secure establishment*
9. secure facilit*
10. reoffend*
11. reincarcerat*
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Table 9. ASSIA (Continued)
12. recidivi*
13. ex-offender*
14. jail or jails
15. incarcerat*
16. convict or convicts
17. convicted
18. felon or felons
19. conviction*
20. reconviction*
21. high security
22. law enforcement
23. Substance abuse* or substance misuse* or substance use*
24. drug dependanc* or drug abuse* or drug use*
25. drug misuse* or drug addict*
26. narcotics addict* narcotics use* narcotics misuse* narcotics abuse*
27. chemical dependanc*
28. opiates
29. heroin
30. crack
31. cocaine
32. amphetamines
33. cocaine
34. addiction
35. dependence disorder*
36. drug involved
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Table 9. ASSIA (Continued)
37. Substance-related disorders
38. amphetamine-related disorders
39. cocaine-related disorders
40. marijuana abuse
41. opioid-related disorders
42. street drugs
43. designer drugs
44. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
45. 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43
46. 44 and 45
Table 10. HMIC
HMIC
1. remand in de
2. detention in de
3. prisoners in de
4. prisons in de
5. offenders in de
6. parole in de
7. probation in de
8. correctional system in de
9. courts in de
10. imprisonment in de
11. criminal justice in de
12. criminal proceedings in de
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Table 10. HMIC (Continued)
13. recidivism in de
14. jail in de
15. institutionalization (persons) in de
16. conviction/convictions in de
17. (remand or prison* or offender* or criminal* or probation or court or courts or secure establishment*) in ti,ab
18. (reoffend* or reincarcerat* or recidivi* or ex-offend* or jail or jails or incarcerat* or secure facilit* or convict* or revocation or
inmate*) in ti,ab
19. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18
20. substance abuse in de
21. explode “Drug-Abuse” in DE
22. “Drug-Injection” in DE
23. explode “Narcotic-Drugs” in DE
24. “Cocaine-” in DE
25. “Addiction-” in DE
26. explode “Psychedelic-Drugs” in DE
27. (substance abuse* or substance misuse* or substance use*) in ti,ab
28. (drug abuse* or drug misuse* or drug use*) in ti,ab
29. (drug dependenc* or drug addict* or narcotics abuse* or narcotics use* or narcotics misuse* or narcotics addict*) in ti,ab
30. (chemical dependenc* or opiate abuse* or opiate misuse* or opiate use* or opiate addict*) in ti,ab
31. (heroin abuse* or heroin misuse* or heroin use* or heroin addict*) in ti,ab
32. (crack abuse* or crack misuse* or crack use* or crack addict*) in ti,ab
33. (cocaine abuse* or cocaine misuse* or cocaine use* or cocaine addict*) in ti,ab
34. (amphetamine* abuse* or amphetamine* misuse* or amphetamine* use* or amphetamine* addict*) in ti,ab
35. (dependence disorder or drug involved) in ti,ab
36. #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35
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Table 10. HMIC (Continued)
37. #19 and #36
Table 11. National Research Register
NRR search
1. REMAND
2. PRISON*
3. OFFENDER*
4. ((CRIMINAL* or PROBATION) or COURT) or COURTS)
5. (SECURE next ESTABLISHMENT*)
6. REOFFEND*
7. REINCARCERAT*
8. RECIDIV*
9. EXOFFEND*
10. ((JAIL or JAILS) or INCARCERAT*)
11. (SECURE next FACILIT*)
12. (((CONVICT* or REVOCATION) or INMATE*) OR (HIGH next SECURITY))
13. PRISONERS:ME
14. LAW-ENFORCEMENT:ME
15. JURISPRUDENCE:ME
16. CRIME:ME
17. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10
18. #11 or #12 or #13 or #14 or #15 or #16
19. #17 or #18
20. ((SUBSTANCE next ABUSE*) or (SUBSTANCE next MISUSE*)) OR (DRUG NEXTDEPENDENC*)) OR (DRUG NEXT
ABUSE*)) OR (DRUG NEXT MISUSE*)) OR (DRUG NEXT USE*)) OR (DRUG NEXT ADDICTION))
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Table 11. National Research Register (Continued)
21. ((NARCOTICS or (CHEMICAL next DEPENDENC*)) OR (OPIATE NEXT ADDICT*)) OR (OPIATE NEXT DEPEN-
DENC*)) OR (OPIATE NEXT ABUSE*)) OR (OPIATE NEXT MISUSE*))
22. ((HEROIN next ADDICT*) or (HEROIN next DEPENDENC*)) OR (HEROIN NEXT MISUSE*)) OR (HEROIN NEXT
ABUSE*))
23. ((CRACK next ADDICT*) or (CRACK next DEPENDENC*)) OR (CRACK NEXT MISUSE*)) OR (CRACK NEXT
ABUSE*)) OR (CRACK NEXT USE*))
24. ((COCAINE next ADDICT*) or (COCAINE next DEPENDENC*)) OR (COCAINE NEXT MISUSE*)) OR (COCAINE
NEXT ABUSE*)) OR (COCAINE NEXT USE*))
25. ((AMPHETAMINE* next ADDICT*) or (AMPHETAMINE* next DEPENDENC*)) OR (AMPHETAMINE* NEXT MIS-
USE*)) OR (AMPHETAMINE* NEXT ABUSE*)) OR (AMPHETAMINE* NEXT USE*))
26. ((ADDICTS or (DEPENDENCE next DISORDER)) OR (DRUG NEXT INVOLVED))
27. (SUBSTANCE-RELATED and DISORDERS:ME)
28. SUBSTANCE-RELATED-DISORDERS:ME
29. AMPHETAMINE-ABUSE:ME
30. COCAINE-ABUSE:ME
31. MARIJUANA-ABUSE:ME
32. OPIOID-RELATED-DISORDERS:ME
33. PHENCYCLIDINE-ABUSE:ME
34. SUBSTANCE-ABUSE-INTRAVENOUS:ME
35. SUBSTANCE-WITHDRAWAL-SYNDROME:ME
36. (STREET next DRUGS)
38. STREET-DRUGS:ME
39. DESIGNER-DRUGS:ME
40. NARCOTICS:ME
41. (COCAINE:ME or AMPHETAMINES:ME)
42. ANALGESICS-ADDICTIVE:ME
43. ANALGESICS-OPIOID:ME
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Table 11. National Research Register (Continued)
44. PSYCHOTROPIC-DRUGS:ME
45. #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37
or #38 or #39 or #40 or #41 or #42 or #43 or #44
46. 19 and 45
Table 12. PAIS
PAIS
1. ((reoffend* or reincarcerat* or recidivi* or ex-offend* or jail or jails or incarcerat* or secure facilit* or convict* or revocation or
inmate*) in ti,ab)
2. ((remand or prison* or offender* or criminal* or probation or court or courts or secure establishment*) in ti,ab)
3. ((drug dependenc* or drug addict* or narcotics abuse* or narcotics use* or narcotics misuse* or narcotics addict*) in ti,ab)
4. ((drug abuse* or drug misuse* or drug use*) in ti,ab) or ((substance abuse* or substance misuse* or substance use*) in ti,ab)
5. ((detox* or methadone maintenance or methadone prescri* or antagonist prescri* or dimorphine or naltrexone) in ti,ab)
6. ((dependence disorder or drug involved) in ti,ab)
7. ((amphetamine* abuse* or amphetamine* misuse* or amphetamine* use* or amphetamine* addict*) in ti,ab)
8. ((cocaine abuse* or cocaine misuse* or cocaine use* or cocaine addict*) in ti,ab)
9. ((crack abuse* or crack misuse* or crack use* or crack addict*) in ti,ab)
10. ((heroin abuse* or heroin misuse* or heroin use* or heroin addict*) in ti,ab)
11. ((chemical dependenc* or opiate abuse* or opiate misuse* or opiate use* or opiate addict*) in ti,ab)
12. ((moral training or cognitive restructuring or assertiveness training or relaxation training) in ti,ab)
13. ((therapeutic communit* or motivational interview* or motivational enhance* or counseling or counselling or psychotherapy or
cognitive behavi*) in ti,ab)
14. ((work ethic or drug education or tasc or treatment accountability) in ti,ab)
15. ((asro or addressing substance or pasro or prisons addressing or acupuncture or shock or boot camp*) in ti,ab)
16. ((arrest referral* or diversion or dtto or dttos or drug treatment or carat or carats or counseling assessment or combined orders)
in ti,ab)
17. ((residential program* or residential scheme* or residential service*) in ti,ab)
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Table 12. PAIS (Continued)
18. ((syringe exchange or dual diagnosis or narcotics anonymous or self help or selfhelp or outreach or bail support) in ti,ab)
19. ((drug-free or drug free or peer support or evaluation* or urinalysis or drug testing or drug use screen* or rehabilitation or discrete
service* or discrete program*) in ti,ab)
20. ((aftercare or after care or brief solution or brief intervention* or 12 step* or twelve step* or minnesota program* or needle
exchange or nes) in ti,ab)
21. ((trigger* or coping skills or anger management or group work or lifestyle modif* or high intensity training or resettlement or
throughcare) in ti,ab)
22. ((self management or interpersonal skills or social skills or basic skills or relapse prevent* or prevent* relapse or craving reduc* or
reduc* craving) in ti,ab)
24. ((rational-emotive or rational emotive or family relationship therap* or community reinforcement or self monitoring or goal
setting or self control training) in ti,ab)
25. #1 or #2
26. #3 or #4 or #5 or #6 or #7 or #8 or 9 or #10 or #11
27. #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24
28. 25 and #26 and #27
Table 13. Criminal Justice Abstracts
CJA search
1. (substance abuse* or substance misuse* or substance use or substance users) in ti,ab,de
2. substance related in ti,ab,de
3. drug related in ti,ab,de
4. (drug dependenc* or drug abuse* or drug misuse* or drug use or drug users or drug addiction) in ti,ab,de
5. (narcotics use or narcotics users or narcotics abuse* or narcotics misuse* or chemical dependenc*) in ti,ab,de
6. (opiates or heroin or crack or cocaine or amphetamines or addict or addicts or addicted or dependence disorder* or drug involved)
in ti,ab,de
7. (designer drugs or street drugs or polydrug misuse* or polydrug abuse*) in ti,ab,de
8. #1 or #2 or #3 or #4 or #5 or #6 or #7
9. ((antagonist near prescri*) or diamorphine or naltrexone) in ti,ab,de
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Table 13. Criminal Justice Abstracts (Continued)
10(therapeutic communit* or (motivational near interview*)) in ti,ab,de
11. (motivational near enhancement) in ti,ab,de
12. (counselling or counseling) in ti,ab,de
13. (psychotherap* or cognitive behav* or behav* therap* or (moral near training)) in ti,ab,de
14. (cognitive restructuring or (assertiveness near train*) or relaxation training) in ti,ab,de
15. (rational emotive or family relationship therap*) in ti,ab,de
16. (community reinforcement or self monitoring or goal setting or goalsetting) in ti,ab,de
17. (self control near training) in ti,ab,de
18. (self management) in ti,ab,de
19. (interpersonal skills near training) in ti,ab,de
20. ((social skills or basic skills) near training) in ti,ab,de
21. ((relapse near prevent*) or (craving near reduc*)) in ti,ab,de
22. (trigger* or coping skills or anger management or group work or (lifestyle near modif*)) in ti,ab,de
23. (high intensity training or resettlement or throughcare or aftercare or after care) in ti,ab,de
24. (brief solution* or brief intervention*) in ti,ab,de
25. (minnesota in ti,ab) in ti,ab,de
26. (12 step* or twelve step*) in ti,ab,de
27. (needle exchange or nes or syringe exchange) in ti,ab,de
28. (dual diagnosis or narcotics anonymous or self help or selfhelp or outreach) in ti,ab,de
29. (bail support or bail program* or arrest referral* or diversion or dtto* or drug treatment) in ti,ab,de
30. (carat or counselling assessment or counseling assessment) in ti,ab,de
31. (combined order* or drug free wing* or drug free environment* or peer support) in ti,ab,de
32. (user evaluations or urinalys* or urinanalys* or drug test* or rehab* or discrete service*) in ti,ab,de
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33. (discrete program* or residential program* or residential scheme*) in ti,ab,de
34. (asro or addressing substance*) in ti,ab,de
35. (pasro or prisons addressing) in ti,ab,de
36. (acupuncture or shock or boot camp or boot camps or work ethic camp*) in ti,ab,de
37. (drug education or tasc or treatment accountability) in ti,ab,de
38. (detoxification or detox or methadone maintenance or (methadone near prescri*)) in ti,ab,de
39. #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26
or #27 or #28 or #29
40. #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39
41. #39 or #40
42. #8 and #41
9. #42 and (PY > “1979”)
WH A T ’ S N E W
Last assessed as up-to-date: 18 May 2006.
Date Event Description
25 March 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 3, 2006
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Date Event Description
19 May 2006 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
Two independent reviewers inspected the search hits by reading the titles and abstracts. Each potentially relevant study located in the
search was obtained as a full article and independently assessed for inclusion by two reviewers. In the case of discordance, a third
independent reviewer arbitrated. Where it was not possible to evaluate the study because of language problems or missing information
the studies were classified as ’translation/information required to determine decision’ until a translation or further details was provided.
D E C L A R A T I O N S O F I N T E R E S T
None
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Department of Health, UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗LawEnforcement; ∗TherapeuticCommunity; Aftercare;Crime [∗prevention&control]; Substance-RelatedDisorders [∗ rehabilitation]
MeSH check words
Humans
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